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Abstract 
In all ecosystems, bacteria are likely to grow in biofilms, and the organisms making 
up the natural flora of the colon are considered to be no exception to this. One of the 
most important hospital-acquired infections is antibiotic associated diarrhoea, with 
the causative agent being the Gram-positive anaerobe, Clostridium dicile. This 
organism elaborates two exotoxins, A and B, which cause disease by interaction with 
the enterocytes of the colon. Treatment of the condition can be difficult, with 
treatment failures not uncommon. As the organism produces a heat stable spore, it 
can survive with ease in the environment. 
4 
There are no previous reports concerned with the study of anaerobes in an in vitro 
biofilm system. The work described here is a study of C. docile, using the Sorbarod 
filter system. This was to determine its suitability in establishing continuous culture 
biofilms of the organism. It was shown that C. docile readily established itself on 
the filters, maintained a titre in excess of 109 cfu/filter for at least 72h. The lack of 
sporulation in the system confirmed that vegetative growth was being maintained. In 
the filters, the organism exhibited elongated forms, sometimes in excess of 10 
microns in length. Electron microscopy showed that this was probably due to lack of 
cell separation at cell division. Toxin production appeared to be higher when C. 
difficile was grown in biofilm in comparison with growth in broth and biofilm 
effluent. 
The susceptibility of the organism to benzylpenicillin, vancomycin, metronidazole 
and rifampicin was determined in broth culture, biofilm and biofilm effluent. Broth 
minimum inhibitory and minimum bacteriocidal (MIC/MBC) experiments showed, 
that apart from rifampicin, the organism was tolerant to the antibiotics. This was 
essentially repeated in the filter system. Rifampicin had a significantly better 
bactericidal activity against the organism, and synergistic killing was achieved when 
rifampicin was combined with vancomycin. 
The growth of C. difficile in biofilm with other common members of the bowel flora 
was investigated in combination experiments with Bacteroidesfragilis, Enterococcus 
faecalis and Escherichia coli. No antagonistic effect was demonstrated and 
antimicrobial susceptibility experiments using C. dicile and E. coli in combination 
showed resistance of both organisms to broad-spectrum antibiotics. Screening for 
bacteriophages and other biological agents with activity against C. docile identified 
an isolate of Lactobacillus paracasei, which had marked activity against the 
clostridium as shown by the "sloppy agar" method, but there was a very variable 
effect in broth and the Sorbarod biofilms. Interestingly, the bacteriocin-like agent had 
activity against not only a number of other clostridial species, but also against 
Streptococcus pneumoniae. 
The work here is thus a novel investigation of an important infection control problem, 
and is the basis for further detailed work examining the growth and pathogenic 
properties of C. dii facile in biofilm. 
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Chapter One 
I 
I Introduction 
1.1 Infective antibiotic-associated diarrhoea 
Pseudomembranous colitis (PMC) was first recognized in 1893 by Finney when he 
described a patient as having a "diphtheritic colitis", which manifested as plaque like 
membranes in the stomach and lower small bowel. There followed similar infrequent 
reports in the literature, and a comparative study of the incidence of the disease 
before and after the introduction of antibiotics did not show a statistically significant 
increase (Pettet et al., 1954). However, as antibiotics were increasingly used, there 
was a notable increase in the incidence of PMC. A study by Tedesco et al. (1974) 
showed a 21 % incidence of antibiotic-associated diarrhoea following clindamycin 
use; half of these patients had sigmoidoscopic evidence of PMC, prompting a 
warning on the package insert for clindamycin. Numerous other antibiotics, including 
ampicillin, were subsequently implicated in PMC. 
Various theories have been postulated for the etiology of antibiotic-associated 
diarrhoea (AAD) and PMC, ranging from a direct effect of the antibiotic/antibiotic 
metabolite on the intestinal flora, to changes in enteric flora, or viruses. In numerous 
early studies, Staphylococcus aureus was considered a significant cause of AAD 
(Dearing et al., 1960; Hummel et al., 1964). Although S. aureus could be isolated 
from the stools of patients with abdominal distress and fever, there were no intestinal 
lesions at autopsy. Despite the discovery of Clostridium docile in 1935, it's role as 
the major causative pathogen in AAD and PMC was not recognized until the late 
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1970s (Larson et al., 1978). Since the link between C. difficile and AAD was 
established, the interest in S. aureus appeared to wane. However, a recent study by 
Gravet et al. (1999) found a ratio of one case of S. aureus AAD for every five cases 
of C. difficile AAD. Methicillin resistance was found in 92% of the implicated S. 
aureus isolates and significantly more AAD S. aureus isolates produced the recently 
described leucotoxin LukE-LukD and staphylococcal enterotoxin A than randomly 
detected strains (Gravet et al., 1998). There is also evidence suggesting that C. 
perfringens may be pathogenic in some cases (Hancock, 1997). The enterotoxin gene 
of C. perfringens isolated from cases with AAD has been found to be located extra- 
chromosomally, differing from the chromosomal position of food-poisoning isolates, 
suggesting that these strains of C. perfringens are a distinct entity (Collie and 
McClane, 1998). Further studies are needed to determine the relative roles of the 
aforementioned bacteria in AAD and PMC. 
1.2 Clostridium difficile 
Clostridia are ubiquitous and are found in soil, decaying vegetation, marine sediment, 
and the intestinal tract of humans, other vertebrates and insects. More than 90 species 
of clostridia are recognized, however fewer than 20 are pathogenic to man. Hall and 
O'Toole (1935) first isolated this organism during a study of intestinal flora of 
newborn infants. It was initially called Bacillus difficilis due to the difficulty 
encountered in its isolation. They described an obligate anaerobic, spore-producing, 
motile Gram-positive rod, which was toxigenic and non-haemolytic. B. difficilis was 
renamed as Clostridium difficile three years later. Cells stain uniformly Gram- 
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positive in young cultures, but may become Gram-negative after 24-48h. Some C. 
difficile strains produce thin capsules, and fimbria-like structures (Borriello et al., 
1990). The production of oval, subterminal spores by C. docile is not associated 
with toxigenic action. Cyloserine, cefoxitin, fructose agar (CCFA) is both selective 
and differential for C. difficile, which characteristically produces a "horse-dung" odor 
(Brazier, 1998). C. d ffcile liquefies gelatin and ferments fructose, glucose, mannose 
and usually. xylose (Hathaway and Johnson, 1998). It produces acetic, isobutyric, 
butyric, isovaleric, valeric, isocaproic, formic and lactic acids in PYG (Peptone 
Yeast-extract Glucose) and converts tyrosine to p-cresol (Holdeman et al., 1977). 
Other important biochemical reactions include production of H2S (Theilman, 2000). 
1.2.1 Epidemiology 
The local importance of C. diffrcile is dependent on multiple factors including 
antimicrobial prescribing practices (spectra of activity and pharmacokinetic 
properties), endemic strains, patient susceptibility to C. diffrcile and criteria used to 
define AAD. Data on the epidemiology of C. diffrcile disease in England and Wales 
from the Communicable Disease and Surveillance Unit, Colindale, indicates a 
dramatic rise in the incidence of this predominantly hospital-acquired infection. 
Laboratory reports in 1997 from England and Wales showed that the total number of 
C. docile toxin-positive cases was approximately 30% higher than in 1996. 
Although C. diffrcile AAD (CDAD) is considered primarily nosocomial, it is a 
problem that is not confined to hospitals. A study by Kyne et al. (1998) reported an 
outbreak of CDAD involving 139 patients in which 11 % of new admissions presented 
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with C. docile cytotoxin B positive diarrhoea; in some cases this was the sole reason 
for hospitalization. National data from Sweden indicates 42% of cases of C. docile 
infection arise in the community (Karlstrom et al., 1998). Community-acquired 
disease may be related to the increasing incidence of nosocomial CDAD, or the more 
widespread use of broad-spectrum antibiotics in General Practice. Sporadic, non- 
antibiotic-related CDAD occurs in the community but is rare. 
A systematic review of the literature to identify risk factors associated with C. 
difficile infection was conducted (Bignardi, 1998). Risk factors for which there was 
evidence suggestive or consistent with an association with C. difficile diarrhoea were 
increasing age, severity of other underlying disease, non-surgical gastrointestinal 
procedures, presence of a nasogastric tube, anti-ulcer medications, stay on ITU, 
duration of hospital stay, duration of an antibiotic course, and administration of 
multiple antibiotics (Brown et al., 1990; McFarland et al., 1990). Some data also 
suggest an association between C. difficile and the use of antineoplastic chemotherapy 
although the effects of antineoplastic agents on the faecal flora remain unknown 
(Anand and Glatt, 1993). The frequent concomitant use of antibiotics and 
chemotherapeutic agents may well mask chemotherapy-induced infection by C. 
difficile, so that its incidence may well be underestimated. The occurrence of severe 
AAD in patients with the acquired immune deficiency syndrome (AIDS) is common 
but appears to be favored relative to both heavy antimicrobial use and general 
immunosuppressive treatment (Cozart et al., 1993). The incidence appears to be the 
same as those in anon-AIDS control group. 
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Studies on the rate of intestinal carriage have been undertaken on all age groups. 
Asymptomatic colonization occurs in approximately 50% of neonates despite stool 
cytotoxin levels that may be similar to those in adults with severe colitis 
(Cooperstock et al., 1983). A possible explanation is the absence of the enterocyte 
membrane toxin receptors in the first year of life. Reported carriage rates in healthy 
adults have varied from 0.3% in Europe to, 15% in Japan (Mulligan, 1988). Serum 
antibodies to C. d ff cile toxins are found in 60% of children and adults in the United 
States and studies suggest that an inadequate immune response may predispose a 
patient to a relapse (Kelly, 1996). 
The hands of personnel, as well as a variety of environmental sites within institutions, 
have been found to be contaminated with C. difficile, which can persist as spores for 
indefinitely (Samore, 1999). Contaminated commodes, bathing tubs, and electronic 
thermometers have been implicated as sources of C. difcile (Savage and Alford, 
1983; Kaatz et al., 1988; Brooks et al., 1992). Symptomatic, and asymptomatic, 
infected patients are the major sources and reservoirs for environmental 
contamination and typing systems are available to aid epidemiological investigations 
(O'Neill et al., 1996). 
1.2.2 Clinical Manifestations 
Infection with toxigenic C. docile causes a spectrum of disease ranging from 
asymptomatic carriage, mild AAD to a fulminant, relapsing, and occasionally fatal 
colitis (Mylonakis et al., 2001). Symptoms usually develop 4-7 days after starting, or 
shortly after stopping, antibiotic therapy, but can develop several weeks after therapy 
ends. It is always important to ask patients with diarrhoea about previous use of 
antibiotics. Most symptomatic patients have explosive, watery, foul-smelling 
diarrhoea with abdominal pain but little overall fluid loss (Tabaqchali and Jumaa, 
1995). Recovery typically ensues within 3 to 10 days with or without specific 
treatment. In PMC, the presenting features may include profuse, persistent diarrhoea, 
fever, cramping abdominal pain and marked leucocytosis (Bulusu et at, 2000). 
General malaise, occult colonic bleeding, dehydration and hypoalbuminemia may 
also be present. Sigmoidoscopy or colonoscopy reveals characteristic adherent yellow 
plaques involving the rectum and sigmoid colon in approximately 90% of cases. 
Proximal colon involvement will be missed if sigmoidoscopy alone is performed 
(Tedesco et at, 1982). Toxic megacolon occurs infrequently but has a high mortality 
rate. Other intra-abdominal complications include: colonic perforation, transverse 
volvulus, protein-losing enteropathy, and recurrent, relapsing AAD (Fekety, 1997). 
Extraintestinal manifestations occur more rarely and include bacteraemia, splenic 
abscess, osteomyelitis, wound infections, peritonitis and urogenital infections 
(Theilman, 2000). Like all other enteric pathogens, C. dfcile has been associated 
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with reactive arthritis; in many cases patients are HLA-B27 antigen-positive (Mermel 
and Osborn, 1989). 
1.3 Pathogenesis 
A sequence of events occurs in the pathogenesis of AAD: disruption of the normal 
enteric flora by antibiotics or antineoplastic agents which have antibacterial activity, 
colonization with C. docile, elaboration of toxin A and toxin B by the organism, and 
subsequent mucosal injury and damage. 
1.3.1 The Role of Antimicrobials 
The administration of antibiotics is considered the most significant and frequently 
reported predisposing factor for CDAD. The colon is home to more than 500 species 
of bacteria and maintenance of a normal bowel ecosystem is one of the main defences 
against C. d ff cile colonization (Borriello, 1998). Even when the organism is present 
in the bowel, suppression by other enteric flora, "colonization resistance, " usually 
prevents disease (Borriello and Barclay, 1986). Almost any antibiotic may cause C. 
diff cile disease, but broad-spectrum antibiotics active against enteric organisms 
allows C. difcile to become established in the bowel (Gorbach, 1999). 
Clindamycin was one of the earliest antibiotics associated with PMC, prompting the 
condition to be called "clindamycin colitis" (Kabins and Spira, 1975). In current 
practice, however, many retrospective studies have shown broad-spectrum penicillins 
and cephalosporins are the commonest culprits, reflecting their widespread use. 
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Parenteral aminoglycosides have never been associated with C. docile infection and 
other low risk antibiotics include rifampicin, quinolones, trimethoprim and the 
ureido-penicillins (Spencer, 1998). The reason for this may reflect the lack of effect 
of some of these antibiotics on endogenous anaerobic gut flora, but this is still 
uncertain. The use of multiple antibiotics has also been shown to increase the risk of 
infection. One study by Gerding et al. (1986) found that patients with C. difficile 
infection were more likely to have received multiple courses of therapeutic antibiotics 
when compared with matched controls. Interestingly, susceptibility to any particular 
antibiotic does not predict the likelihood of CDAD following exposure to that agent. 
Despite the fact that most strains of C. docile are susceptible to aminopenicillins, 
even these antibiotics can precipitate C. docile infection. C. difcile colonization 
and disease develop more commonly after prolonged antibiotic agents, but has also 
been reported with some antimicrobial agents used for short-term (S three doses) 
perioperative prophylaxis (Privitera et al., 1991). A study by Kreisel et al. (1995) 
showed that not only is a prolonged prophylactic antibiotic course in elective surgical 
cases associated with increased risk of developing C. d fcile toxin positivity, but the 
choice of antibiotic is also important. There are now sufficient reports in the literature 
to limit the widespread use of cephalosporins, especially in at risk populations such as 
the elderly, by the substitution, where possible, with antibiotics not associated with 
the promotion of AAD (Department of Health and Public Health Laboratory Service 
Joint Working Group, 1994). Widespread education about the rational prescribing of 
antibiotics in clinical practice remains of paramount importance. 
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1.3.2 Virulence factors of C. difficile 
C. difficile produces a number of virulence factors including colonization factors and 
toxins, which contribute to infection. As with all pathogens, not all strains are equally 
virulent (Borriello et al., 1987). One study in a hamster model demonstrated that 
some serotypes produced more toxins in vivo than others (Delmee and Avesani, 
1990). Factors such as the production of spores, proteolytic and hydrolytic enzymes, 
expression of fimbriae and flagella, chemotaxis and adhesion to gut receptors, and 
production of capsules, may all play a part in pathogenesis by facilitating colonization 
or by directly contributing to tissue damage, or both (Borriello, 1998). 
When established in the colon, pathogenic strains of C. dfJcile produce 2 major 
toxins that cause diarrhoea and colitis, as well as 3 minor toxins C, D, and E 
(Borriello et al., 1990). These 2 major exotoxins have been well characterized: toxin 
A, a 308-kd enterotoxin, and toxin B, a 279-kd cytotoxin. Both toxins have 
contiguous repeating units at the COOH terminus and overall, the two toxins exhibit 
49% homology at the amino acid level (Kyne et al., 2001). Toxin A causes fluid 
secretion, mucosal damage, and intestinal inflammation and probably causes most of 
the clinical symptoms (Pothoukalis, 1996). Toxin A is also a chemoattractant for 
human neutrophils in vitro. Toxin B is approximately 1000 times more potent than 
toxin A as a cytotoxin in tissue culture but is not enterotoxic in animals (Pothoukalis 
et al., 1986). The molecular organization and control of both toxins is now starting to 
be understood with the sequencing of the genes encoding them, which are arranged 
on a 19.6 kb toxicon in a chromosomal pathogenicity locus with the minor toxins 
10 
(Cohen et al., 2000). Once the toxins gain access to the cytoplasm of the enterocyte, 
both inactivate Rho proteins, guanosine triphosphate-binding proteins, that regulate 
actin cytoskeleton and various signal transduction processes (Pothoukalis, 1996). 
Toxin-induced dysregulation of Rho leads to cytoskeleton disruption, cell rounding 
and retraction, and apoptosis in cell lines. Differential expression between strains of 
various combinations of these colonization and virulence factors may explain the 
apparent variability in virulence of C. difficile strains. Toxigenic strains of C. difficile 
had been reported to produce both toxins A and B nearly always, and non-toxigenic 
strains are reported to produce neither of these toxins. Recent studies indicate that this 
is not always true. Strains which produce toxin B but not toxin A (A-B+) have been 
described in a case report of PMC caused by such a strain, which suggests that toxin 
A may not be the main pathogenic factor of C. difficile infection, as previously 
thought. The prevalence of such strains still appears to be low, but is variable, with a 
described incidence of 31 % in one Canadian hospital (Embil et al., 1999). No strains 
have yet been described that express A but not B. 
1.4 Diagnosis of C. difficile-related infection 
The diagnosis of CDAD should be based on both clinical, as well, as laboratory 
findings. A review of the criteria for optimal diagnosis of infections due to C. docile 
was performed by Gerding and Brazier (1993). Key elements included the patient's 
clinical history and symptoms, endoscopic evidence of a colonic pseudomembrane, 
laboratory evidence of C. docile in stool, and laboratory evidence for toxin(s) in 
stool. 
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1.4.1 Clinical diagnosis 
There are numerous risk factors and host factors that should prompt the attending 
clinician to consider C. docile infection, in either the hospital or community setting. 
Advancing age (>65y) is one the cardinal factors associated with symptomatic 
infection. A carefully taken drug history detailing recent antibiotic use (strong 
associative risk but not a complete prerequisite), or other medications including 
cytotoxic drugs, antacids, and laxatives might alert to a diagnosis of C. dff cile 
infection. 
Diarrhoea is the most common clinical symptom, but this can be difficult to define as 
patients' bowel habits differ considerably and their "normal bowel habit" must first 
be elucidated. Diarrhoea is defined by a variety of criteria such as six watery stools 
over 36 hours, three unformed stools in 24 hours, or eight unformed stools over 48 
hours (Gerding et al., 1995). Other causes for diarrhoea should also be sought when 
suspecting AAD. Ward staff may also suspect AAD as it has a distinctive scent (horse 
manure) and this may also play an early role in diagnosis and reduction of horizontal 
transmission. A response to empirical treatment for AAD is also suggestive of the 
diagnosis but should be confirmed by the laboratory. Rarely, <1%, symptomatic 
patients do not have diarrhoea due to ileus (Kelly et al., 1994). It is therefore 
important to communicate with the laboratory to test the non-diarrhoea) stool for C. 
difficue or it's toxins when suspected. 
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1.4.2 Endoscopy 
Characteristic adherent yellow plaques, involving the rectum and sigmoid colon in 
90% of cases, are the pathognomonic lesions found on endoscopy in the patient with 
PMC. The intervening mucosa may appear normal or erythematous and in severe 
cases, the plaques may coalesce to cover large areas of mucosa (Fekety, 1997). 
Biopsy may reveal changes associated with PMC in those cases where endoscopic 
findings are non-specific (Fekety et al., 1993). 
1.4.3 Laboratory diagnosis 
The correct specimen for the diagnosis of AAD is a loose or watery stool, which 
should be submitted as soon as possible to the laboratory for testing. Numerous 
studies have shown that storage at ambient temperatures may result in possible 
denaturation of toxin so where it is not possible to test expediently, specimens should 
be refrigerated or frozen. In most cases of infection, toxin testing or C. difficile 
culture readily establishes the diagnosis; however repeat testing or endoscopy or both 
may be necessary. Studies by Bouza et al. (2001) showed that combination of direct- 
cell culture assay, culture for toxigenic C. docile and "second-look" cell culture 
assay also enhances the potential for diagnosis of CDAD. Table 1 summarizes the 
characteristics of the different tests used to diagnose CDAD. Methods such as stool 
gram stain, analysis for faecal leucocytes, counterimmunoelectrophoresis of stools for 
toxin production, and direct chromatography of stool have only been marginally 
successful (Brazier, 1998). A combination of C. difficile culture and one nonculture 
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based test for toxin has been recommended as the optimal laboratory approach but 
stool toxin testing alone has also been recommended (Gerding and Brazier, 1993; 
Walker et al., 1986). 
Test Sensitivity (%) Specificity (%) Clinical Utility 
Endoscopy 51 -100 Diagnosis of PMC 
Culture 89-100 84-99 Highly sensitive; confirmation 
of toxicity optional . 
Cell culture cytotoxin test 67-100 85-100 With clinical data, diagnostic 
of AAD 
EIA toxin test 63-99 75-100 With clinical data, diagnostic 
of AAD - 
Latex test for C. difcile 
antigen 
58-92 80-96 Less sensitive and specific than 
others tests, rapid results 
PCR toxin gene detection Undetermined Undetermined Research test 
Modified from Gerding et al. (1995 
Table 1 Sensitivity and Specificity of Tests for Diagnosis of C. docile -associated 
Diarrhoea 
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1.4.3.1 Culture 
Traditionally, culture is the method for diagnosing bacterial infections. 
Hafiz and Oakley attempted to produce the first selective media in 1976 using p- 
cresol. Others, however, subsequently found that p-cresol is in fact inhibitory to the 
growth of C. d ff cile leading to other selective media being devised (Brazier, 1998). 
The description of an egg yolk agar base medium containing cycloserine, cefoxitin 
and fructose (CCFA) by George et al. (1979) has led to a culture method which has a 
good success rate in recovery of C. docile from stool specimens. Various 
modifications of antibiotic concentrations have been tested but, despite increasing the 
enhancement of growth of C. difficile, have made the agar less selective by allowing 
other microbes to grow. Mundy et al. (1994) suggested using CCFA plates that had 
been reduced anaerobically for 4 hours before use. Strains of C. difficile typically 
produce flat, yellow, ground glass appearing colonies with a surrounding yellow halo 
in the middle (Gerding et al., 1995). Visual inspection of colonial morphology on this 
agar and confirmation by Gram stain is sufficient for a confirmation of C. docile 
(Peterson et al., 1986). 
Further identification can be performed either biochemically or by Gas-Liquid 
Chromatography (GLC). As C. difficile is a spore-bearing bacillus, procedures such 
as alcohol-shock treatment of stool specimens have been reported to increase the 
culture yield by selecting for sporulating organisms (Bartley and Dowell, 1991). 
Culture may not be considered either cost-effective or timely by many laboratories 
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that prefer using more rapid tests such as ELISA-based assays for toxin detection, but 
it remains essential for epidemiological studies of outbreaks (Riley et al., 1995). 
Laboratories that adopt culture as the sole means of testing for C. docile diarrhoea 
can expect a high false positive rate as determination of toxin production is necessary 
to distinguish pathogenic toxigenic strains from non-pathogenic non-toxigenic strains 
(Shanholtzer et al., 1992). 
Latex testing for the C. docile protein, glutamate dehydrogenase, is also available 
for direct use on stool specimens but various studies show sensitivity rates of 58% to 
68% and a specificity of 94% to 96% (Gerding et al., 1995). Disadvantages of this 
test are lack of an isolate for epidemiological investigations and no information on the 
toxigenicity of the isolate. 
1.4.3.2 Toxin determination 
Detection of toxin activity in stools from patients with antibiotic-associated colitis 
was the initial observation leading to the discovery of C. dii frcile as the causative 
agent of this infection (Larson et al., 1977). Toxin B manifests itself as a cytopathic 
effect (CPE) on cell lines causing a rounding-up of cells and this forms the basis for 
the cytotoxic assay for toxin B in stools (Brazier, 1998). Toxin A is also 
cytotoxigenic and can be detected in this assay. Assay for the cytotoxins of C. difficile 
can be performed in almost any cell line but some are more sensitive than others 
(Thelestam and Bronnegard, 1980). Vero, Hep2, monkey kidney and HeLa cells are 
generally used. The detection of cytotoxin in tissue culture is considered the "gold 
16 
standard" with which other diagnostic tests are compared in evaluations of sensitivity 
and specificity (De Gromlami et al., 1992). A faecal suspension is made in 
phosphate-buffered saline (PBS), centrifugued and the supernatant is then filtered 
through a 0.2µm membrane filter. The filtrate is then inoculated onto a cell 
monolayer, which is examined at 24h and 48h for a CPE. To confirm it's specificity, 
any CPE should be compared with a negative PBS control and be neutralizable with 
either C. difficile or C. sordellii antitoxin. Disadvantages of this methodology include 
its slowness (however, there have been some reports of detectable CPE in 70% of 
specimens in 6h) and having access to tissue culture cell lines (Brazier, 1998). 
Several commercial enzyme immunoassays are now widely used for the detection of 
C. docile toxins and are considered to be reasonable alternatives because of their 
good specificity, rapid turnaround time, convenience and cost. Most of the kits are 
designed to detect toxin A but a few detect both toxins (Lyerly et al., 1998). There 
have been recent reports of A-B+ toxigenic strains and it is now recommended to 
adopt the use of a kit that tests for both toxins. An automated immunodiagnostic 
assay system for toxin detection has been made available from Vitek (Hazelwood, 
MO, USA) but sensitivity and specificity rates are poor by comparison with the gold 
standard of the cytotoxicity assay (Riederer et al., 1995). 
1.4.3.3 Molecular methods 
The advent of methods based on the polymerase chain reaction (PCR) for detecting 
nucleic acid specific for a given gene or organism in a clinical specimen has led to 
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research in its applicability to the diagnosis of C. difficile infection (Wren et al., 
1990). Research has been mainly targeted at the direct amplification of the genes for 
toxin production. Early results look promising and it is thought that one major benefit 
of this direct method could be epidemiological typing of environmental and patient 
strains. Application of molecular methods will require that they have good sensitivity, 
specificity, and speed compared to culture and cytotoxin assay, and that they can be 
performed at a competitive cost (Gerding et al., 1995). 
1.5 Treatment of C. difficile 
The treatment options for C. difficile infection remain limited, although promising 
agents are currently being assessed. Initial therapy of patients with PMC should 
include discontinuation of the offending antibiotic regimen, if possible, and 
replacement of fluid and electrolyte losses. Studies have indicated that approximately 
15-25% of patients respond to this approach alone but most patients require specific 
antibacterial therapy (Olson et at, 1994). If the patient has a concomitant infection 
that does require treatment, an antibiotic that has a reduced risk of exacerbating the C. 
difficile infection should be substituted along with the addition of an antibiotic to treat 
C. difficile. Antiperistaltic agents such as loperamide should be avoided as several 
case series have suggested they may predispose to an increased mortality with the 
development of toxic megacolon (Fekety, 1997). These agents promote colonic stasis 
so may theoretically contribute to further damage and inflammation due to prolonged 
mucosal exposure to C. dijcile toxins. 
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1.5.1 Initial Treatment 
Either oral metronidazole (400mg 8h) or oral vancomycin (125mg 6h) are the 
recommended first-line agents and are equally effective in treating C. d ff cile 
infection (Wilcox and Spencer, 1992; Zimmermann et al., 1997). Symptomatic 
improvement generally occurs within 72h, and diarrhoea and colitis resolves in 95% 
of patients after 10 days of treatment. Although vancomycin has preferable 
pharmacokinetics (it is not appreciably absorbed from the gastrointestinal tract (GIT)) 
and good killing activity against C. docile (Kucers and Bennett, 1987), restriction to 
second-line therapy reduces the emergence of glycopeptide resistance. Metronidazole 
is readily absorbed from the GIT and systemic side effects may occur, however, it is 
more cost-effective and does not pose a risk factor for colonization and infection with 
vancomycin resistant enterococci (VRE) (Delmee et al., 1995). Metronidazole- 
resistant strains of C. docile had been reported sporadically until a recent Spanish 
report worryingly described widespread metronidazole resistance in a HIV positive 
population (Pelaez et al., 1997). There also have been reports of metronidazole 
inducing diarrhoea (Saginur et al., 1980). 
Patients who cannot tolerate oral medication because of paralytic ileus, nasogastric. 
suctioning, intestinal obstruction or recent abdominal surgery can be effectively 
treated with intravenous metronidazole as excretion into the inflamed colon from the 
bile results in bactericidal levels in the faeces (Bolton and Culshaw, 1986). However, 
parenteral failures with metronidazole have also been reported (Guzman et at, 1988). 
Reports of success with intravenous vancomycin are limited due to low intracolonic 
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levels. One case had undetectable faecal levels of vancomycin despite 5 days of 
parenteral therapy (Tedesco et al., 1978). Vancomycin has also reportedly been 
administered as an enema and via a long catheter placed during colonoscopy but the 
safety and efficacy of this practice is questionable (Pasic et al., 1993). It has also been 
suggested that intravenous empirical therapy should consist of both antibiotics 
(Wilcox, 1998). 
1.5.2 Relapses 
Many patients suffer a relapse of diarrhoea from C. diffrcile infection when initial 
therapy is discontinued. In a recent UK study, repeat courses of antibiotic treatment 
were given to 37% of those patients requiring antimicrobial therapy for C. diffrcile 
infection (Wilcox et at, 1996). It was not know whether the high clinical failure was 
due to relapses or reinfections. Both may be related to the formation of antibiotic 
resistant spores (Tedesco et at, 1985). Relapse is defined clinically as a re-occurrence 
of diarrhoea following a symptom free period (Wilcox, 1998). One molecular 
fingertyping study showed that 56% of relapses were in fact due to reinfection with a 
different strain (Wilcox et at, 1998). The diagnosis of recurrent diarrhoea from C. 
diffrcile infection should be confirmed by a stool toxin study but it is not necessary to 
use this test as a confirmation of cure or eradication in asymptomatic patients. Many 
who continue to have positive toxin results do not develop a relapse. Treatment may 
not be necessary for mild symptomatic relapses, since they resolve spontaneously. It 
is common practice to switch from metronidazole to vancomycin (or vice versa) in 
patients with symptomatic recurrences. In recalcitrant relapse cases various 
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approaches have been suggested including a slow tapering of vancomycin therapy for 
4-6 weeks (the rationale being primary killing of vegetative C. docile and secondary 
killing of germinated resistant spores), the use of rifampicin in combination treatment 
or other antimicrobials including fusidic acid, bacitracin and teicoplanin (Kyne et al., 
2001). 
New treatment options are still awaited. Pelaez et al. (2002) examined the in vitro 
activity of linezolid against C. difficile, including those with reduced susceptibility to 
metronidazole or vancoymcin and MICs were always 5 4mg/L, and thus, all isolates 
were susceptible. These data are promising but further studies on the efficacy of 
linezolid in cases of CDAD are needed. McVay et al. (2000) described the activity 
against C. difficile of a new nitrothiazole benzamide agent, nitazoxanide. In vitro 
activity was similar to that of vancomycin or metronidazole. Unfortunately, studies of 
the in vitro activity of new quinolones against C. docile were not as promising 
(Alonso et al., 2001). Alternatives to using antibacterials include biotherapy and 
immunological approaches (Roffe, 1996; Salcedo et al., 1997). 
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1.5.3 Alternative therapies 
Biotherapy aims to restore the commensal gut flora and hence colonisation resistance 
against C. dicile. Probiotics have special properties that make them useful in 
fighting infections of mucosal surfaces such as the gut and vagina. They are 
becoming increasingly available as capsules and dairy-based food supplements sold 
in health care shops and supermarkets. Several small series of patients have been 
21 
treated for, or received prophylaxis against, AAD with biotherapy, including 
Lactobacillus acidophilus, Lactobacillus GG, Enterococcusfaecium SF 68, non- 
toxigenic C. difficile, yoghurt, brewer's yeast or Saccharomyces boulardii (Wilcox, 
1998). Rectal infusions of normal faeces and bacterial enemas incorporating various 
facultatively aerobic and anaerobic bacteria are measures that have been tried in those 
that have failed to respond to traditional antibiotics (Tvede and Rask-Maden, 1989). 
A randomized placebo-controlled trial of S. boulardii in combination with standard 
antibiotics for C. difficile infection reported efficacy in terms of symptomatic 
recurrence rates but no data was provided to differentiate relapses from reinfections 
(McFarland et al., 1994). It is thought that S. boulardii may effect the proteolytic 
digestion of toxins A and B by a secreted protease (Castagliuolo et al., 1999). Two 
case reports of fungaemia have highlighted the inherent dangers associated with yeast 
formulations used in treating C. docile infection (Niault et al., 1999). In another 
study, two patients with relapsing C. difficile diarrhoea following standard treatments 
of both metronidazole and vancomycin were colonised with a non-toxigenic avirulent 
strain of C. docile with symptomatic improvement (Seal et al., 1987). A meta- 
analysis suggests that probiotics can be used to prevent AAD and that S. boulardii 
and lactobacilli have the potential to be used in this situation (D'Souza et al., 2002). 
Further work to look at the costs of and the need for routine use of these agents needs 
to be undertaken. 
The nature of the immune response to C. docile infection is being investigated and 
may pave the way for vaccine development and other types of immunotherapy. 
22 
Serum IgG against toxin A is thought to play an important protective role against C. 
difficile in patients who remain asymptomatically colonised and likely explains an 
observation that patients who are already colonised with C. difficile on admission to 
hospital are significantly less likely to develop symptomatic infection (Kyne et al., 
2000). This study also reports significantly higher levels of both serum IgM and IgG 
antibodies against toxin A in patients who experienced single compared with multiple 
episodes of CDD. The role IgA plays in C. difficile infection is uncertain. 
Nonetheless, passive or active immunotherapy could potentially be used to prevent or 
treat C. docile infection. In a study of 6 children with relapsing C. difficile colitis, 
Leung et al. (1991) found that these children had low serum levels of IgG antibody 
against toxin A. Treatment with normal pooled intravenous gamma globulin, which 
contained IgG anti-toxin A, was associated with a marked increase in serum antitoxin 
antibody levels and resolution of recurrent C. difficile infection. A bovine 
immunoglobulin concentrate has been reported to inhibit the cytotoxicity and 
enterotoxicity of C. difficile toxin (Kelly, 1996). Immunotherapy looks a promising 
approach for treating C. docile infection but further work is needed. 
1.5.4 Surgery 
Approximately 1 to 3% of patients with C. difficile colitis develop signs and 
symptoms of disease requiring admission to an intensive care unit (Synott et al., 
1998). Some of these severely ill patients require lifesaving emergency colectomy 
because of impending perforation, severe ileus with megacolon, or refractory 
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septicaemia. Indications for surgery include peritoneal signs, bacteremia 
unresponsiveness to antibiotics, progressive fever, rigors, an elevated white cell 
count, or CT scan evidence of significant pericolonic inflammation with increasing 
bowel wall odema (Synott et al., 1998). Various surgical procedures have been 
described, including ileostomy, cecostomy, or decompressive colostomy but the 
recommended procedure is subtotal colectomy with ileostomy (Agnifili et al., 1994). 
This can be converted to an ileorectal anastomosis after colonic inflammation has 
subsided. The overall mortality rate in cases requiring surgery is around 30 to 35% 
(Morris et al., 1990). 
1.6 Antimicrobial Susceptibility Testing and Resistance Patterns of C. difficile. 
The mainstay of treatment for C. docile colitis is either the imidazoles 
(metronidazole) or glycopeptides (vancomycin). Other antimicrobials such as 
rifampicin have been used in combination therapy (Buggy, 1993). In vitro 
determination of C. docile susceptibility to these antibiotics is not routinely 
performed in most laboratories. The reference method for susceptibility testing of 
anaerobic bacteria is the agar dilution method as recommended by the British Society 
for Antimicrobial Chemotherapy (BSAC) and the National Committee for Clinical 
Laboratory Standards (NCCLS, 1997). This method is appropriate for reference 
laboratories only as it is time-consuming and poorly adapted to the analysis of a few 
isolates. Poilane et al. (1999) compared the Etest with the reference dilution, method 
to determine the susceptibility of C. difficile to antibiotics used in therapy, in order to 
have a rapid, reliable and easy-to-use method. Ninety eight percent of the Etest 
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Minimum Inhibitory Concentrations (MICs) were within one dilution of the agar 
dilution MICs, however, the authors advised ensuring that the test conditions are well 
controlled for metronidazole testing. 
Resistance patterns of C. docile remain imprecise due to lack of laboratory 
surveillance data (Brazier, 1998). Studies have shown that this bacterium is highly 
susceptible to metronidazole (MIC 0.06 -2mg/L), vancomycin (MIC 0.125-4mg/L), 
and teicoplanin (MIC 0.03-2mg/L) (Dzink, 1980). Niyogi et al. (1992) found all C. 
difficile strains to be uniformly susceptible to metronidazole and penicillin G but 
highly resistant to gentamicin, trimethoprim, sulphamethoxazole, nalidixic acid, 
cycloserine and cefotaxime. The susceptibility of 50 random C. docile isolates 
submitted for typing in 1996 (representing 18 PCR ribotypes and about 14% of the 
total number of isolates) was assessed by the Anaerobe Reference Laboratory in 
Cardiff, Wales (PHLS, 2002). This study, showed no resistance to metronidazole, 
vancomycin or co-amoxiclav but resistance was reported to pipercillin/tazobactam 
(4%), chloramphenicol (6%), tetracycline (8%), penicillin (14%), clindamycin (20%), 
erythromycin (46%), imipenem (96%) and cefoxitin (100%). 
After a report by a Spanish group who described an emerging problem of C. diffrcile 
strains with reduced metronidazole susceptibility (Pelaez et al., 1998), reassessment 
of C. diffrcile susceptibility to metronidazole and vancomycin over an 8-year period 
(1993-2000) was undertaken by this group (Pelaez et al., 2002). The overall rate of 
resistance to metronidazole at the critical breakpoint (16mg/L) was 6.3% and 
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although full resistance to vancomycin was not observed, the overall rate of resistance 
was 3.1%. A French retrospective study looked at a collection of C. difficile strains 
from 1991 and 1997 (Barbut et al., 1999). Strains with decreased susceptibility to 
metronidazole (MIC Z8 mg/L, NCCLS breakpoint) were isolated from 6 patients 
(n=4 in 1991 and n=2 in 1997). Strains isolated in 1997 were surprisingly more 
susceptible than those isolated in 1991, and this trend correlated to a major change in 
serogroup distribution. Further reports of metronidazole resistance from China are 
documented in the literature (Wong et al., 1999). Metronidazole resistance has also 
been reported in an environmental isolate from an elderly care ward in Leeds, which 
was typed as PCR ribotype 10, a non-toxigenic ribotype (Brazier et al., 2001). 
Metronidazole remains an inexpensive, highly effective treatment for CDAD and it 
will be important to ascertain the clinical impact of metronidazole-resistant strains. 
Hopefully, a scenario similar to that experienced by 4 US hospitals, who had 
outbreaks of CDAD by a strain that was highly resistant to clindamycin, will not 
occur (Johnson et al., 1999). In the current era of evolution of resistance, especially to 
glycopeptides, with the appearance of V11E, glycopeptide-intermediate S. aureus 
(GISA) and vancomycin-resistant S. aureus (VRSA), it is apparent that ongoing 
antimicrobial resistance surveillance is warranted. 
1.7 Infection Control and Prevention 
C. docile can be isolated from the stools of asymptomatic patients as well as from 
symptomatic patients. Patients with diarrhoea excrete larger numbers of organisms in 
faeces and bacterial spores have been found in abundance in the environment of 
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patients with disease (Mulligan et al., 1979). Contaminated environmental surfaces 
and healthcare workers (HCWs) handcarriage are considered important vectors for 
transmission in hospitals (McFarland et al., 1989). The frequency of C. docile 
handcarriage amongst HCWs significantly correlates with the intensity of 
environmental contamination (Strimburg et al., 1989). 
Infection due to C. d ff cile is almost entirely confined to persons who have been 
made susceptible by antibiotic therapy that removes the protective flora of the 
gastrointestinal tract. The key to prevention is good control of antibiotic use, use of 
infection control universal precautions and good environmental cleaning. Thus, an 
effective infection control programme should target the interruption of horizontal 
spread of the organism (to keep the patient from acquiring the organism), and 
minimalise the risk of organism exposure resulting in clinical infection (Worseley, 
1998). 
1.7.1 Control of Antibiotic Usage 
Antimicrobial use is very common in all hospitalised patients with AAD; Clabots et 
al. (1992) found that 72% of patients with ward acquisitions had had antibiotics 
within the previous fourteen days. Specifically, clindamycin, ampicillin or 
cephalosporins pose as major risk factors for C. difficile infection as well as various 
dosing parameters (number of doses, number of antibiotic days and use of 
combination therapy) (Bignardi, 1998). Where appropriate, narrow spectrum 
antibiotics should be used whenever possible, preferably those antibiotics with a 
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lower potential for inducing C. d ff cile infection (Spencer, 1998). Empirical or 
"blind" therapy should usually be prescribed for serious infections. Ideally, where 
delay does not endanger the patient, microbiological results should be awaited to both 
confirm an infective disease and aid in choosing a more "bowel friendly" antibiotic. 
Review of drug charts regularly should be encouraged so that antibiotics can be 
discontinued when infections have been treated. Good control of antibiotics should be 
encouraged at all times, however, in the wake of an outbreak, it is essential that 
rational prescribing is strictly policed as spores of C. difficile can persist in the 
environment for months (Worseley, 1998). Changing of antibiotic policies to reduce 
the use of cephalosporins and clindamycin is also a useful measure in controlling 
outbreaks of C. difficile. A change of antibiotic policy for the treatment of 
community-acquired pneumonia was implemented at an UK hospital with a resultant 
decline in nosocomial acquisition of C. docile and the number of bed days occupied 
by infected patients (Jones et al., 1998). There may also be merit in the use of 
prophylactic agents that could reduce the risk of CDAD in patients who are receiving 
antibiotics, e. g. S. boulardii (Surawicz et al., 1989). 
1.7.2 Routine Infection Control Procedures 
Primary prevention of C. docile also includes good routine infection control 
practices. The use of isolation techniques (enteric precautions, private rooms, and 
cohorting of infected patients) has been employed for outbreak control (Worseley, 
1998). The practice of cohorting patients when there are no available side-rooms may 
lead to reinfection from others members of the cohort or from a heavily contaminated 
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ward. Handwashing remains an essential infection control measure as poor 
handwashing plays a key role in the transmission of infection in the hospital setting 
(Johnson et al., 1990). The literature shows evidence for poor compliance with this 
relatively simple task. There has been much debate about the merits of differing 
handwashing agents and the use of gloves. A study by Bettin et al. (1994) compared 
the effectiveness of liquid soap with that of Hibiscrub (4% chlorohexidine gluconate 
in 4% alcohol, Zeneca Pharma, UK) for decontaminating bare hands or gloved hands 
inoculated with an epidemic strain of C. docile. The results showed no significant 
difference in residual counts on bare hands but on gloved hands the residual counts on 
bare hands were higher following a chlorhexidine wash than a soap wash. Enteric 
precautions should be adopted for all patients with diarrhoea, disposable gloves and 
aprons should be worn when handling body fluids. The patient also should be 
educated about basic infection control measures they can take in reducing nosocomial 
transmission. 
1.7.3. Environmental Cleaning and Disinfection 
C. difficile infection may arise from endogenous carriage or exogenous acquisition 
into the gastrointestinal tract. There is much evidence documenting the contamination 
of the hospital environment with C. diJcile, so, primary prevention measures should 
be targeted towards it (Savage and Alford., 1983). Environmental contamination has 
been linked to spread of C. d ff cile via a contaminated commode chair; nursery baby 
baths and contaminated rectal thermometers (Larson et al., 1982; Savage and Alford, 
1983; Brooks et al., 1992). The risk of transmission via contaminated endoscopes 
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appears to be low if scopes are properly cleaned and disinfected using 2% alkaline 
glutaraldehyde immersion for as little as 5 minutes (Hughes et al., 1986). Studies 
have shown that the rate of environmental contamination rises in proportion to the 
status of the patients in the area, being lowest for rooms of culture negative patients 
(<8%), intermediate for rooms of asymptomatic patients (8-30%), and highest (9- 
50%) for rooms with patients with AAD (Gerding et al., 1995). Ideally, ward rounds 
should begin with patients in the "clean" area, i. e. non-infected patients, and finish 
with infected patients. 
There is a paucity of data regarding the efficacy of different cleaning agents and 
disinfectants for C. difficile. The American College of Gastroenterology recommends 
that instruments and contaminated surfaces in rooms of patients with C. difficile 
diarrhoea should be disinfected using alkaline gluteraldehyde, sodium hypochlorite, 
or ethylene oxide (Fekety, 1997). The UK guidelines recommend detergent-based 
hospital cleaning agents to remove environmental C. difficile (Department of Health 
and Public Health Laboratory Service, 1994), but findings from a study by Wilcox 
and Fawley (2000) imply that routine cleaning with detergent is often unsuccessful at 
removing C. difficile from the environment. Sporulation of the UK C. difficile 
epidemic strain, which produces significantly more spores than non-prevalent strains, 
was further enhanced when cultured in faecal emulsions exposed to non-chlorine- 
based hospital cleaning agents compared with two chlorine-releasing agents (Wilcox 
and Fawley, 2000). These findings question the UK guidelines as the use of detergent 
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cleaning agents may actually increase the environmental persistence of some C. 
difficile strains. 
1.8 Bacteriocins 
Amongst the variety of toxins produced by bacteria, some act against other bacteria. 
Those that do go under the umbrella term of bacteriocins and consist of a diverse 
collection of molecules ranging from short peptides to large 80-kDA proteins (James 
et al., 1992). Bacteriocins are one of the most abundant and varied classes of 
antimicrobial molecules, having been detected in all major lineages of Eubacteria and 
in all Archaebacteria (James et al., 1991). They are potent, often highly specific 
toxins that are usually produced during stressful conditions and result in the rapid 
elimination of neighbouring cells that are not immune or resistant to their effect. It 
has been proposed, given their narrow spectrum of activity, that their primary role is 
to mediate intraspecific, or population-level, interactions while causing little or no 
harm to the host bacterium due to posttranscriptional modification and/or specific 
immunity mechanisms (Riley and Gordon, 1999). 
The state of bacteriocin classification requires constant review as the knowledge 
concerning various aspects of bacteriocin research rapidly accumulates and it appears 
that the term bacteriocin has been used to cover a wide range of chemically diverse 
substances that do not necessarily have much in common. One class of bacteriocins, 
the colicins, produced by Escherichia coli, has been the focus of numerous studies 
that suggest that colicins play a key role in mediating E. coli population dynamics. 
(Riley and Gordon, 1999). A variety of antimicrobial peptides are produced by lactic- 
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acid bacteria (LAB) and include Class 1 (lantibiotics) and Class 11 (small heat-stable 
non-lanthionine-containing peptides). The prototype LAB bacteriocin, nisin, was first 
discovered by Rogers (1928) when he observed metabolites of Streptococcus lactis 
(now reclassified as Lactococcus lactis) that were inhibitory to other LAB. The 
successful commercial application of nisin in the preservation of a number of 
processed foods and the growing concerns of the approaching "Post-Antibiotic Era" 
has generated considerable interest in developing potential novel applications for 
bacteriocins. 
1.8.1 Nature and distribution 
Hundreds of bacteriocins have been described in the past-century. These peptides can 
be differentiated into those, which are non-ribosomally synthesized (such as the 
gramicidins and bacitracins) and ribosomally synthesized (natural) peptides. 
Bacteriocins have a wide variety of sequences and structures but certain features are 
common (Hancock and Lehrer; 1998). These peptides are generally 12-50 aminoacids 
in length, tend to have a net positive charge due to an excess of basic over acidic 
residues and contain around 50% hydrophobic aminoacids. They fold into three- 
dimensional amphiphilic structures due to the presence of disulphide bridges. Thus, 
their hydrophilic domains are well separated from the hydrophobic domains. 
Bacteriocins fit into four structural classes which include ß-sheet molecules stabilized 
by two or more disulfide bonds, amphipathic a-helices extended molecules, and loops 
due to a single disulphide bond (Hancock, 2001). The ß-sheet and a-helical 
molecules are by far the most common in nature. 
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1.8.2 Mechanism of Action 
The mechanisms by which bacteriocins act has become a complex issue. It can be 
difficult to predict either the activity of a bacteriocin or the secondary structure it will 
form by the amino acid sequence alone. Numerous model membrane studies all 
observe that the interaction of these peptides with the bacterial cytoplasmic 
membrane is an essential step in the peptides' bactericidal activity (Piers et al 1993, 
Oren and Shai, 1998) and a variety of hypotheses have been postulated to explain 
bacterial killing. Bacteriocins act by either permeabilizing the outer cell membrane of 
Gram-negative bacteria and disrupting its integrity, or having crossed the cell 
membrane (or the thick cell wall in Gram-positive bacteria) it has been proposed that 
they act on the nucleic acids of bacteria or trigger autolysis (Wu et al., 1999). A 
number of peptides have been shown to bind to lipopolysaccharide (LPS) and to 
permeabilize the outer membrane to self-promote uptake into Gram-negative bacteria. 
The affected outer membrane is thought to develop transient "cracks" which permit 
the passage of a variety of molecules, including the uptake of the peptide itself. After 
these initial interactions, the mode of bacterial killing is not clear. Many peptide 
molecules will then insert into the cytoplasmic membrane interface and are proposed 
to either aggregate into a micelle-like complex which spans the cytoplasmic 
membrane or flip-flop across this membrane under the influence of the large 
transmembrane electric potential gradient (Falla et al., 1996). The micelle-like 
aggregates are proposed to have water associated with them, and this provides the 
channels for the movement of ions across the membrane and possibly leakage of large 
33 
water-soluble molecules. These aggregates will dissociate into monomers that may be 
disposed at either side of the membrane. The net effect is that some monomers will be 
translocated into the cytoplasm and can dissociate from the membrane and bind to 
cellular polyanions such as DNA and RNA (Hancock and Chapple, 1999). The 
bactericidal effect of bacteriocins tends to be extremely fast and it is difficult to 
monitor the stages of bacterial killing. It is important to understand how these 
peptides act to fully exploit their potential use as antimicrobial agents 
1.9 Biofilms 
C. difficile, being associated with AAD, is a major health problem, especially in the 
elderly, hospitalized patient. Contamination of the ward environment with spores of 
the organism, and the difficulty in their eradication, highlight the importance of C. 
difficile as an infection control issue. Most bacteria can grow as biofilms, and it is 
known that the growth characteristics and antibiotic susceptibility patterns of bacteria 
in biofilms can often be very different to those found in bacteria grown under 
standard laboratory conditions (Gander 1996; Donlan, 2001). It is recognized that, in 
the complex ecosystem of the colon, bacteria grow in biofilms and bacterial biofilms 
can cause environmental problems (MacFarlane et al., 1997). A biofilm system seems 
appropriate to study the more natural state C. difficile in the outside environment and 
the colon. 
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1.9.1 Definition of Biofilms 
It has long been appreciated that bacteria can adhere to solid surfaces and form a 
slimy coat, yet the fact that the biofilm mode of existence, with sessile bacteria, 
constitutes a major component of the bacterial biomass in many environments was 
only accepted in the 1970s. Biofilms have been described in many systems since Van 
Leeuwenhoek examined the "animalcules" in the plaque on his own teeth in the 
seventeenth century. The definition of biofilms has changed over the last 25 years 
with the increasing understanding of the genetic and molecular basis of this bacterial 
community. Marshall (1976) noted the involvement of "very fine extracellular 
polymer fibrils" that anchored bacteria to surfaces. Costerton et al. (1999) observed 
that communities of attached bacteria in aquatic systems were found to be encased in 
a "glycocalyx" matrix that was found to be polysachharide in nature, and this matrix 
material was shown to mediate adhesion. Characteristics of spatial and temporal 
heterogeneity and involvement of inorganic or abiotic substances held together in the 
biofilm matrix was defined by Characklis et at. (1990). Further studies showed that 
adhesion of bacteria to a surface triggered expression of genes controlling production 
of bacterial components necessary for adhesion and biofilm formation (Costerton et 
al., 1995). The current definition of a biofilm is a microbially derived sessile 
community characterized by cells that are irreversibly attached to a substratum or 
interface or to each other, are embedded in a matrix of extracellular polymeric 
substances that they have produced and through which channels for the circulation of 
nutrients are found, and exhibit an altered phenotype with respect to growth rate and 
gene transcription (Donlan and Costerton, 2002). 
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1.9.2 Formation of Biofilms 
Biofilms are universal and virtually any surface - animal, mineral, or vegetable (i. e. 
biotic or abiotic) - is suitable for bacterial colonization and biofilm formation. 
Substrata for biofilm formation vary greatly from very hydrophobic materials, various 
plastics, latex, and silicone, to highly charged hydrophilic materials such as glass and 
various metals. The characteristics of the substratum may have a significant effect on 
the rate and extent of attachment by microorganisms (Donlan and Costerton, 2002). 
Generally, rough hydrophobic surfaces develop biofilms more rapidly. The 
characteristics of the cell surface are equally important as the presence of flagella, 
pili, fimbriae, or glycoclayx may impact on the rate of microbial attachment 
(Mittleman et al., 1992). Bacterial biofilms are formed from individual planktonic 
cells in a complex developmental process. The life cycle of a biofilm involves the 
transition from individual free-swimming cells to communities of bacteria adhered to 
a surface, followed by a subsequent return to a planktonic existence. 
The process of biofilm formation can be divided into 3 steps: primary bacterial 
adhesion, secondary bacterial adhesion, and biofilm maturation (Costerton, 1999). 
The process of bacterial adhesion is dictated by a number of variables, including the 
species of bacteria, surface composition, environmental factors, and essential gene 
products. Primary adhesion involves the meeting of a planktonic microorganism and a 
conditioned surface. The organism is either propelled randomly or in an organized 
fashion (by chemotaxis and motility) towards the respective surface. Adhesion will 
ensue dependent on the net sum of the attractive or repulsive forces generated 
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between the organism and surface. These forces include electrostatic and hydrophobic 
interactions, steric hindrance, van der Waals forces, temperature, and hydrodynamic 
forces (Carpentier and Cerf, 1993). 
The second stage of adhesion is the anchoring phase and employs molecularly 
mediated binding between specific adhesives and the surface (An et al., 2000). 
Loosely bound organisms consolidate the adhesion process by producing 
exopolysaccharides that complex with surface materials and/or receptor-specific 
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ligands located on pili and fimbriae, or both. Adhesion becomes irreversible in the 
absence of chemical or physical intervention, and the organisms become firmly 
attached to the surface (Dunne, 2002). Planktonic organisms can also stick to each 
other or different species of surface bound organisms, forming aggregates on the 
substratum. 
Once bacteria have irreversibly attached to a surface, the process of biofilm 
maturation begins. The density of the biofilm increases as the surface-bound 
organisms begin to actively replicate (and die) and extracellular polymeric substances 
(EPSs) such as generated by attached bacteria interact with organic and inorganic 
molecules in the immediate environment to generate the glycocalyx. These EPSs 
consist primarily of polysaccharides and can be detected microscopically and by 
chemical analysis. They are highly hydrated (98% water) and bind tenaciously to the 
underlying surface. The structure of the biofilm is not merely a homogenous 
monolayer of slime but is heterogeneous with water channels throughout. 
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or acquired (i. e., caused by the acquisition of resistance plasmids). At least 3 reasons 
are suggested for the intrinsic antimicrobial resistance of biofilms. The first 
hypothesis is the failure of an antibiotic to penetrate the full depth of the biofilm. 
EPSs retard diffusion either by chemically reacting with the antimicrobial molecules 
or by limiting their rate of transport. Hoyle et al. (1992) showed that the EPSs of 
Pseudomonas aeruginosa was capable of binding tobramycin; dispersed cells were 15 
times more susceptible to this agent than were cells in intact biofilms. Antibiotics 
have been shown to penetrate biofilms readily in some cases and poorly in others, 
depending on the particular agent and biofilm (Hoyle et al., 1992). The second 
hypothesis depends on an altered chemical microenvironment within the biofilm. 
Studies using microelectrodes have shown that oxygen can be completely utilized in 
the outermost layers of a biofilm, such that deeper layers become anaerobic. 
Aminoglycoside antibiotics are less effective against the same microorganism in 
anaerobic than in aerobic conditions. Some bacteria in a biofilm experience nutrient 
limitation and exist in a slow-growing or quiescent state (Zhang and Bishop, 1996). 
As many antibiotics target rapidly dividing cells, these organisms manage to evade 
cell death. 
A third speculative reason for reduced susceptibility is that a subpopulation of micro- 
organisms in a biofilm forms a unique, and highly protected phenotypic state (Stewart 
and Costerton, 2001). This phenotype is not a response to nutrient limitation; it is a 
biologically programmed response to growth on a surface. This hypothesis is lent 
support by findings from studies that show resistance in newly formed biofilms, even 
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though they "are too thin to pose a barrier to the penetration of either an antimicrobial 
agent or metabolic substrates (Das et al., 1998; Cochrane et al., 2000). 
A novel hypothesis has recently been postulated by Lewis (2001) for antimicrobial 
resistance in biofilm mode of growth and it relates to the potential of damaged 
bacterial cells to undergo apoptosis or programmed cell death. Lewis suggests that 
lysis of cells after bactericidial agents is secondary to a programmed apoptosis and 
not a direct result of the antibiotic. It is postulated that biofilm cells may be defective 
in programmed cell death and may persist, albeit damaged, during therapy (Brooun et 
al., 2000). After removal of the antibiotic, the damaged cells proliferate, engendering 
recalcitrance on the biofilm community. 
With regard to acquired resistance, research has shown that plasmids can be 
exchanged in biofilms under many conditions. Ehlers and Bouwer (1999) 
demonstrated plasmid transfer by conjugation between different Gram-negative 
bacteria growing in biofilms. The transfer rates of plasmids horizontally were several 
orders of magnitude higher in biofilms than in liquid culture of the same organisms. 
This may be a result of the greater probability of contact between cells and the 
negligible effect of shear forces in either disrupting cell-to-cell contact or damaging 
the pili required for conjugation. 
Standard susceptibility testing, which challenges planktonic cells with an 
antimicrobial agent, will not accurately predict the efficacy of an agent against 
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biofilm-associated organisms. Neither the NCCLS or BSAC have an approved 
method for evaluating the effectiveness of antimicrobial agents against biofilm- 
associated organisms. 
In order for a biofilm system to have a use in routine antimicrobial susceptibility 
testing, it must be able to fulfill criteria including reproducibility, provision of a 
meaningful range of results, minimal risk of contamination to system, have a simple 
system for delivery of media to, and collection of effluent from all biofilms 
(Struthers, 2000). A variety of methods have been used to test several antimicrobial 
agents against biofilms of microorganisms (Table 2). A concern with any of these 
biofilm susceptibility testing methods is how closely they can approximate to an in 
vivo or an in situ biofilm. 
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Apparatus Organism(s) 
Tested 
Flow 
dynamics 
Substratum Method for removing 
and quantifying biofilm 
Reference 
Modified Robbins P. pseudomallei Batch/mixing Silastic disks Not given. Vorachit et al., 
device 1993 
Calgary biofilm device P. aeruginosa, Batch/mixing Plastic pegs Viable count Ceri et al, 
S. aureus, E. coli 
Sonicate peg, then viable 1999 
count 
Disk reactor Gram-negative Batch/mixing Teflon coupons Sonicate, vortex, Donlan et al, 
bacteria 
homogenize, then viable 1999 
or direct count 
CDC reactor Gram-negative Continuous/open Needleless Sonicate, vortex, Murga et at, 
Bacteria 
connectors homogenize, then count 2001 
Sorbarod filter model P. aeruginosa Continuous/open Cellulose- Vortex in ringers, then Struthers, 
S. pneumoniae 
acetate filters viable count 2000 
Model bladder Gram-negative Continuous/open Urinary Direct exam" by Scanning Stickler and 
bacteria 
catheters or Transmission Electron Hughes, 1999 
Microscopy 
odified from Donlan and Costerton, 20 
Table 2. Apparatuses that have been used for growing and testing biofilms 
1.9.4 Biofilms and Infection 
It can be appreciated that the environments suitable for micro-organisms to colonize 
and establish biofilms are practically endless. To the benefit of human beings, they 
confer colonization resistance to infection, assist the absorption of nutrients from the 
bowel and are critical to biodegradation. Biofilms are, however, more often 
associated with problems. They not only cause oral disease such as dental caries and 
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peridontitis but also are strongly implicated in the pathogenesis of native valve 
endocarditis and cystic fibrosis (Donlan and Costerton, 2002). A biofilm link has also 
been suggested for otitis media and chronic prostatitis (Nickel et al., 1994; Donlan 
and Costerton, 2002). Infections of implanted devices, industrial biofouling and 
public health issues related to food hygiene and provision of potable water are also 
associated with biofilms (Costerton et al., 1987; Carpentier and Cerf, 1993). Biofilms 
of medical devices have been extensively studied over the last 20 years and infections 
of prosthetic heart valves, central venous catheters, urinary catheters, contact lenses, 
intrauterine devices, and dental unit water lines are well described (Donlan and 
Costerton, 2002). Research has elucidated the susceptibility of various materials, such 
as urinary catheters and contact lenses, to bacterial adhesion and biofilm formation. 
Biofilm infections share clinical characterisitics. They develop preferentially on inert 
surfaces, or on dead tissue, and occur commonly on medical devices and fragments of 
dead tissue such as sequestra of dead bone (Lambe et al., 1991); they can also form 
on living tissues, such as in the case of infective endocarditis. Biofilms grow and 
produce overt symptoms slowly. Antigens are released from biofilms and these 
stimulate antibody production (Cochrane et al., 1988). This host immune response is 
ineffective in killing bacteria within the biofilm and may cause immune complex 
damage to surrounding tissues. Bacterial biofilms are a common cause of persistent 
infections, which show recurring symptoms, after cycles of antibiotics, until the 
sessile population is removed from the body. If an indwelling medical device is 
colonized by a biofilm, the problem will inevitably get worse, and the aging biofilm 
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will become increasingly difficult to treat. If organisms with acquired resistance are 
present in the biofilm, the probability of resistance-plasmid transfer might increase 
over time. Biofilms can act as "niduses" of acute infection if host defenses cannot 
eliminate the planktonic cells that are released at any one time during the infection 
(Costerton et al. 1999). 
1.9.5 Biofilm Systems 
Studying biofilms in the environment can be difficult because of their heterogeneous 
nature. Laboratory models can be used to provide more reproducible and defined 
conditions. In this way a number of different models have been developed to 
investigate biofilm growth (Buswell et al., 2001). These include (i) flow cells; (ii) 
channel reactors; (iii) Robbins devices; (iv) rototorque; (v) packed bed reactors; (vi) 
airlift reactors; (vii) constant depth film fermentors; (viii) chemostat bioreactors and 
(xi) Sorbarod filter system. There is a vast range of experimental systems with which' 
to develop biofilms, and the model used depends on the nature of the problem that 
one is investigating. Flow cells using glass are useful when the investigator wants to 
follow attachment using light microscopy combined with fluorescent dyes for species 
specificity or viability assays (Caldwell and Lawrence, 1988). Flow regimes in pipe 
work can be modeled using the Robbins device, which can simulate different 
scenarios such as urinary catheters (McCoy et al., 1981). 
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1.9.5.1 Sorbarod Filter System 
This is a simple model, which employs the use of Sorbarod filter plugs which are 
perfused with culture media (Struthers, 2000). Sorbarods are cylindrical cellulose 
fibre plugs. They are constructed with creped wood cellulose fibre running the length 
of the filter and wood cellulose wrap. There is a trace of polyvinyl acetate adhesive to 
seal the ends of the paper wrap. Initially they were used in the horticultural industry 
for the micropropagation of plant tissue (Conkie, 1988; Donkin and Price, 1989) and 
are now being adopted in microbiology for research. These cellulose Sorbarod filters 
provide a large surface area on which bacteria can adhere and grow and enable the 
rate of growth, expression of target proteins and effect of antibiotics on biofilm mode 
of growth to be studied (Hodgson et al., 1995). The extensive inter-fibre spacing 
allows for the free flow of liquid media thus helping to prevent blockage of the 
system. The system can employ a 12 channel peristaltic pump, enabling 12 Sorbarod 
filters to be run in one experiment (Struthers, 2000). Hodgson et al. (1995) employed 
this biofilm technique for long-term culture and growth rate of S. aureus and P. 
aeruginosa. These organisms established steady states which were stable over several 
days at which the growth was reproducible, measurable and slower than in broth 
culture. Significant differences between the protein profiles of biofilms and the 
planktonic populations of S. aureus were demonstrated. The Sorbarod filter system 
has been used for antimicrobial susceptibility testing of biofilms. There are sufficient 
individual biofilms available in one experiment to cover a meaningful range of 
antibiotic concentrations, and it allows for I or 2 control biofilms to be run 
simultaneously. It has been used to investigate the susceptibility of S. pneumoniae to 
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various (3-lactam antibiotics; with this organism it was shown that the biofllm mode 
of growth did not reduce it's susceptibility (Budhani and Struthers, 1997). 
The Sorbarod system has also revealed unique structures associated with cell division 
in Gardnerella vaginalis, (Muli and Struthers, 1998) and that S. pneumoniae 
reversibly lost it's capsule when grown on these filters (Budhani et al., 1998; Waite et 
al., 2001). Unlike growth in batch culture, biofilms of type 3 pneumococci were 
found to generate small acapsular colonies at high frequency when plated on to blood 
agar. A significant proportion of these reverted to typical, large capsular colonies on 
subculture, although the frequency with which reversion occurred varied. 
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In this work, the Sorbarod filter system was used to study phenotypic characterisitics 
of C. difficile in the biofilm mode of growth. 
Clostridium difficile ranks as one of the most important causes of hospital acquired 
infection. The Sorbarod biofilm system has been used in the investigation of a range 
of medically important bacteria. As anaerobes have not been investigated in biofilm, 
this system has the potential to provide useful information on C. d ffcile, which may 
be relevant to its survival in the environment and in the colon. 
The aims of the study were: 
1. To investigate the appropriateness of the Sorbarod filter system for biofilm 
growth of C. docile. 
2. To investigate the morphology of C. docile grown in biofilm, broth and plate 
cultures to determine if there are any differences in the morphology. 
3. To investigate the expression of pathogenic properties (toxins A and B) of C. 
difficile in Sorbarod biofilms and compare this to broth culture. 
4. To determine the Minimum Inhibitory Concentrations (MIC), Minimum 
Bactericidal Concentrations (MBC), and Biofilm Eradicating Concentrations 
(BEC) of selected antibiotics used in treating C. difficile infection. 
5. To investigate combination growth of various organisms with C. difficile and 
expose multiple organism biofilms to various antibiotics. 
6. To screen stool specimens for bacteriophages and bacteriocins active against C. 
difficile and to characterize these entities where possible. 
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Chapter Two 
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2 Materials and Methods 
2.1 Organisms and their maintenance 
The, major organisms used in this study were Clostridium dffficile (a clinical strain 
from a patient at Walsgrave Hospital, Coventry, clinical strains from Beaumont 
Hospital, Dublin, and NCTC strain 11204). Other organisms also used were 
Enterococcusfaecalis (clinical strain), Escherichia coli (clinical strain), Bacteroides 
fragilis (NCTC 9343), Streptococcus pneumoniae (clinical strain), Listeria 
monocytogenes (NCTC 11994), Staphylococcus epidermidis (NCTC 11047), Bacillus 
cereus (NCTC 7464), Haemophilus influenzae (NCTC 4560), Neisseria lactima 
(clinical strain), Salmonella poona (NCTC 4840), Pseudomonas aeruginosa (NCTC 
10662), Shigella sonnei (NCTC 8574), Klebsiella pneumoniae (NCTC 9633), 
Acetinobacteur baumanii (clinical strain), Clostridium perfringens (NCTC 8237), 
Clostridium bifermentans (NCTC 506), Clostridium novyi (NCTC 538), Clostridium 
tetani (NCTC 279), Clostridium sporogenes (NCTC 532), Clostridium butyricum 
(NCTC 7432) and Lactococcus paracasei (isolated from horse manure). 
For the storage of cultures for longterm preservation, a heavy suspension of 
organisms was inoculated onto beads (Microbank, PRO-LAB Diagnostics, Ontario, 
Canada) which were then stored in a -70°C freezer (Cryo King Ultralow). In order to 
obtain organisms for daily experimental work, one bead of the desired organism was 
removed from the -70°C freezer, and subcultured onto 7% Columbia blood agar 
plates. Subsequent subcultures from beads were performed every 6 weeks. 
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2.2 Media, reagents and antibiotics 
2.2.1 Media used 
The commercially acquired agar, media and reagents for this study were Colombia 
Blood agar, Colombia Agar Base, Colombia Agar Technical (Agar No. 3) Base, 
Colombia C. dfJcile Agar Base, Brain Heart Infusion media, C. dicile selective 
supplements (Oxoid, Basingstoke, Hampshire, UK), and defibrinated horse blood 
(Bioscience, Buckingham, UK). Media and agar were prepared as per the 
manufacturer's instructions using deionised water, dispensed into the required 
volumes and autoclaved at 121°C for 15 minutes. Brain heart infusion (BHI) broth 
was used for the growth of C. diýcile and feedbroth for biofilms. The stock formula 
of BHI is shown in Table 3. Sloppy agar, (0.5%) and (0.75%), and 1.5% agar base 
were prepared using Agar No. 3 base with BHI media. 
Ingredient gram/Litre 
Calf brain infusion solids 12.5 
Beef heart infusion solids 5.0 
Proteose peptone 10.0 
Glucose 2.0 
Sodium chloride 5.0 
Disodium phosphate 2.5 
pH 7.4 
Table 3 The stock formula of BHI 
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2.2.2 Selective Media 
C. dicile selective media was prepared by the addition of 7% (v/v) defibrinated 
horse blood and C. docile selective supplements (D-cycloserine 125mg and 
cefoxitin 4mg) after the selective agar base media (see Table 4 for stock formula) was 
autoclaved and cooled to 57°C. For combination growth experiments, additional 
selective media were made with Agar Base No. 3 to which various antibiotics were 
added, depending on the selectivity required (Adatabs, Mast Laboratories Ltd., 
Merseyside, UK). Aztreonam (3.2mg), gentamicin (0.8mg) and trimethoprim (0.8mg) 
Adatabs were used. 
Ingredients am/Litre 
Proteose peptone 40.0 
Disodium hydrogen phosphate 5.0 
Potassium dihydrogen phosphate 1.0 
Magnesium sulphate 0.1 
Sodium chloride 2.0 
Fructose 6.0 
Agar 15.0 
Table 4. The stock formula of Clostridium docile agar base 
2.2.3 Antibiotics 
The following antibiotics were used in susceptibility testing, benzylpenicillin, 
(560: 600 potency) (Britannia, Redhill UK), amoxicillin-clavulanic acid (5: 1) 
(SmithKline Beecham, Worthing UK), meropenem (AstraZeneca, Luton, UK), 
metronidazole (Aventis Pharma, Kent UK), rifampicin (Aventis Pharma), and 
51 
vancomycin (Lilly, Basingstoke, UK). All antibiotics used were freshly prepared. The 
stock solutions were prepared in sterilized deionised water. 
23 Growth conditions 
Unless otherwise stated organisms were usually incubated in an anaerobic incubator 
(MACs, Don Whitley Scientific Ltd., Shipley, UK) at 37°C. 
2.4 Viable Counts 
In order to determine the surface viable counts of bacteria, an adaptation of the 
technique of Miles et al. (1938) was employed. The Sorbarod filter was suspended in 
5mL of Ringers' solution (Central Media Supplies, PHLS, Colindale, London, UK), 
disrupted by agitation using sterile loops and then vortexed. Twenty µL of either this 
filter suspension or effluent suspension were mixed with 180µL BHI broth in a 
microtitre well followed by titration in ten-fold serial dilutions in the same broth. 
Aliquots (10µL) of the appropriate dilutions were plated in triplicate onto Colombia 
blood agar plates, allowed to dry before inversion, and then plates were incubated 
anaerobically (or aerobically when selection of C. docile was not desired) at 37°C 
for 48h. The titre (colony forming units (cfu) per mL. ) was then determined from the 
mean of the triplicate readings by employing the formula: 
Average number of colonies/dilution 
Volume of inoculum x bacterial dilution 
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Titres for biofilm effluent were expressed as cfu/mL, and the biofilm titre was 
expressed as total recoverable cfu/filter. This was obtained by multiplying the cfu/mL 
by a factor of 6.57 (accounts for the volume of the 20-mm length x 10-mm diameter 
filter plus the 5mL of Ringers solution added before vortex mixing). 
2.5 Sorbarod Biofilm System 
The Sorbarod filter system was assembled according to the method described by 
Struthers (2000), shown in diagrammatic and photographic representations of the 
system Fig 1,2, and 3. Cellulose Sorbarods 10mm in diameter and 20mm in length 
(Ilacon, Tonbridge, Kent, UK) were placed in 10cm lengths of silicone tubing with an 
internal diameter of 10mm. These were then connected by tubing (0.8mm internal 
bore) to a feed bottle of BHI broth (Oxoid, Basingstoke, UK). The effluent end of the 
Sorbarod filter was connected via plastic adapters to replaceable 150mL sterile glass 
bottles which enabled collection of effluent fluid at any time interval during the 
investigation. The entire biofilm apparatus consisting of BHI feedbroth supply, 
connecting tubes, Sorbarod filters and effluent bottles were then autoclaved at 121°C 
as a single unit. This minimised the chance of contamination. Each Sorbarod filter 
was pre-wetted with 3mL of BHI broth before inoculation with 3mL overnight broth 
culture of C. di icile, or other organisms such as E. coli, E. faecalis, B. fragilis or L. 
paracasei which were studied in combination experiments. 
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The BHI feedbroth was delivered by a 12 channel 205U peristaltic pump (Watson 
Marlow, Falmouth, UK) at a usual flow rate of 4. OmIJh. The whole apparatus with 12 
biofilms was placed in an anaerobic incubator at 37°C. At each assay time point, 
effluent was collected over 15 minutes so that the number of viable planktonic 
bacteria was determined. Biofilms were titrated as described previously. 
Once the steady state of growth of organisms in biofilm was achieved (Chapter 3), 
each individual biofilm was exposed to a single antibiotic concentration for 18h for 
differing antibiotics. This change to antibiotic containing BHI broth was achieved by 
use of T connector tubing, upstream from the biofilm, enabling a switch from BHI 
feedbroth to a particular antibiotic concentration made up in I00mL of BHI broth. For 
each set of experiments, 12 individual Sorbarods were prepared to allow for one 
control antibiotic free biofilm and sufficient individual test biofilms which were 
exposed to different concentrations of antibiotics to cover a meaningful range. Each 
biofilm and effluent with and without antibiotic was titrated in triplicate. 
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A 0.8 mm Silicone tubing 
g Yellow tip 
ýý 
j u/ 
C Cap 
D 10.0 mm Silicone tubing 
E Sorbarod filter 
FV shaped connector 
G Screw cap 
Fig. 1A diagrammatic representation of the biofilm apparatus showing a 20 x 10mm 
biofilm in a silicon PVC tubing. Medium was supplied to each biofilm at a flow rate 
of 6mLlminute and effluent was collected in 150mL replacable bottles. 
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Fig 2. Photograph of Sorbarod filter (10mm x 20mm length) which consists of a 
paper sleeve encasing compacted concertina of parallel cellulose fibres running 
the length of the Sorbarod. 
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Fig 3. Photograph of the complete biofilm apparatus. 
Medium was supplied to each biofilm at a flow rate of 4mL/minute and 
effluent was collected in 150mL bottles. 
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2.6 C. difficile Enzyme Immunassay for Toxins A/B 
Toxin studies were performed on both C. dilcile broth, biofilm and effluent 
specimens using an enzyme immunoassay kit (Ridascreen® Clostridium difcile 
Toxin AB, R-Biopharm AG, Darmstadt, Germany; Table 5). Supernatant specimens 
of biofilms and effluents, which had been collected at different time intervals from 
the growth curve experiments, were stored at -70°C. After thawing and mixing, test 
samples, positive controls and negative controls were pipetted in fifty µL aliquots into 
separate wells of the 96 microwell plate (Greiner BIO-ONE, Stonehouse, 
Gloucestershire, United Kingdom). A drop of biotin conjugate was added and mixed 
and the plate was incubated for 90 minutes at room temperature. All wells were 
decanted into a waste container with disinfectant. A total of 4 wash cycles, using 
250µL washing buffer was performed. One hundred µL of streptavidin conjugate was 
then added to the wells and incubated at room temperature for 30 minutes. Washing 
was then performed 5 times. Finally a third incubation was done for 30 minutes at 
room temperature in the dark following the addition of 50µL substrate and 50µl of 
chromogen into each well. The reaction was stopped by adding 50µL of stop solution 
and the absorbency was measured at 450nm using a bioelisa plate reader (BIO-TEK 
Instruments, Winoosk, VT, USA). 
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Microwells coated with monoclonal antibodies against Toxin A and B 
Universal stool diluent, containing buffered NaCl (negative control) 
Washing buffer, pH 7.2, containing 0.1% thimerosal 
Positive control, partially denatured toxin (0.1% sodium azide) 
Biotin conjugate, biotinylated antibodies against Toxins A and B 
Streptavidin Conjugate (HRP-conjugated) 
Substrate, urea peroxide 
Chromogen (tetramethylbenzidine) 
Stop solution (1M sulfuric acid) 
Table 5. Reagents in EIA test kit for Clostridium dicile Toxin A/B (Ridascreen®) 
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2.7 Susceptibility testing 
2.7.1 Disk sensitivity testing 
Disk sensitivity testing was performed on C. dicile, E. coil, E. faecalis and B. 
fragilis. The BSAC susceptibility methodology was used (www. bsac. org. uk). 
Ampicillin, aztreonam, colistin, gentamicin, rifampicin, trimethoprim and 
vancomycin were used. 
2.7.2 Determination of Tube Minimum Inhibitory and Bactericidal 
Concentrations 
Minimum inhibitory concentration (MIC) is the lowest concentration of antibiotic at 
which there is no visible growth of an organism (turbidity), while the minimum 
bactericidal concentration (MBC) is the lowest concentration that prevents growth 
after subculturing on antibiotic free medium (Lambert et al., 1997). Stock solutions of 
the various antibiotics (benzylpenicillin (560/600), metronidazole, rifampicin and 
vancomycin) were prepared. Dilutions were carried out in order to achieve antibiotic 
concentrations to cover a meaningful range; 32µg/mL - 0.004µg/mL. The dilutions of 
antibiotic made in BHI broth (lmL) were inoculated in duplicate with diluted (10.2) 
overnight broth cultures of C. dicile isolates (100µL). MICs were determined 
following overnight anaerobic incubation. Subculture of all non-turbid broths was 
done to determine the MBC. 
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2.7.3 Etest Susceptibility Testing 
The Etest (Epsilometer) is a technique for quantitative antimicrobial susceptibility 
testing which allows for the direct determination of inhibitory concentration. In order 
to control MIC and MBC tests, the Etest (Cambridge Diagnostics Services, 
Cambridge, UK) was performed according to the manufacturers instructions. Etest 
strips contain a continuous gradient of antimicrobial agent (discontinuous twofold 
dilutions) on the underside of the strip, which diffuses out into the media, when the 
strip is placed on the surface of the agar plate. Inhibition of growth appears in the 
shape of an ellipse, and the MIC is read where the zone edge or ellipse intersects the 
Etest strip. From the fresh overnight culture of C. diJcile on blood agar, a suspension 
was prepared in 0.85% sterile saline and adjusted to a1 McFarland barium sulphate 
turbidity standard. Using a sterile swab, the inoculum was streaked onto a 
defibrinated horse blood agar plate and incubated anaerobically for 24-48 hours and 
the plates were then read. 
2.7.4 Biofilm Eradicating Concentration (BEC) and Effluent Minimum 
Bactericidal Concentration (EfMBC) 
Sorbarod filters were inoculated, according to the method of Budhani and Struthers 
(1997), with 3m1 of overnight C. dii facile broth to allow growth to become established 
for 24h. A single antibiotic concentration (range of 32mg/L - 0.004mg/L, prepared in 
100ml of BHI broth) was run into each established Sorbarod biofilm at a flow rate of 
4. OmIJh for eighteen hours. After this time effluent was collected for 15 min. in order 
61 
to determine the titre of planktonic bacteria. The individual Sorbarod filter was then 
harvested in 5mL of Ringers solution and vortexed to disintegrate the cellular matrix. 
Titrations were then performed on both effluents and the disintegrated filters in 
triplicate by an adaptation of the method of Miles et al. (1938) using sterile 96 well 
microtitre plates (Greiner BIO-ONE, Gloucestershire, UK). The biofilm eradicating 
concentration (BEC) and the biofilm effluent MBC were those concentrations of an 
antibiotic that eliminated the organisms from the biofilm filter and effluent 
respectively. 
When titration of combination experiments of two organisms in biofilm were done, 
selective media was used. When E. coli and C. difcile were grown together, E coil 
was selected by aerobic growth and C. . 
ricile was selected by growth anaerobically 
on Bill agar containing gentamicin. Enterococci were also selected by growth 
aerobically but were inhibited by growth on BHI agar containing trimethoprim. B. 
fragilis grew on agar containing vancomycin but not on BHI agar containing 
aztreonam, allowing for the selection of both C. dcile and B. fragilis when grown 
under anaerobic conditions. Selection of Lactobacillus paracasei was achieved by 
growth under aerobic conditions and C. docile was selected by growth on C. docile 
selective agar (Oxoid, Basingstoke, Hampshire, UK) when experiments were 
conducted using both organisms. 
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2.8 Microscopic techniques 
2.8.1 Light microscopy 
Cell suspensions from broth, biofilm and effluents were examined under the light 
microscope after they were stained by the Gram method which involves applying 
ammonium oxalate-crystal violet stain for 30 seconds, washing in water, applying 
Lugol's iodine solution for 30 seconds, then decolourising with a few drops of 
acetone before couterstaining with weak carbol fuchsin for 30 seconds and washing 
under tap water (Lillie, 1928). 
These cell suspensions were also stained for spores by Schaeffer and Fulton's method 
(1933). Fixed slides were flooded with 5% aqueous malachite green and steamed for 
one minute. After washing under running water, the slides were counterstained with 
0.5% aqueous safranin for 15 seconds. The slides were rinsed again with tap water 
and dried before viewing under the light microscope (Nikon Digitial Net camera 
DN 100). 
2.8.2 Transmission Electron Microscopy 
Methods used were essentially those described in Kay (1967). In order to prepare 
samples for Transmission Electron Microscopy, two methods were employed that 
included the diffusion fixation of bacteria for preparation of bacterial sections and 
whole cell preparations for negative staining. 
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2.8.2.1 Preparation of bacteria for sectioning 
Bacterial pellets were prepared from plates, broths and biofilms of C. docile 
harvested at different time intervals. The pellets were resuspended and fixed for 2 
hours in 5m1 of 2.5% (v/v) glutaraldehyde in 0.1mL sodium cacodylate buffer pH 7.2, 
containing 0.15% (v/v) ruthenium red (Marrie and Costerton, 1984). Rutheniun red 
staining allows preservation of EPS matrix (Costerton et al., 1981). After fixing, a 
pellet was collected after centrifugation and the supernatant discarded. The cells were 
washed five times in cacodylate buffer, post fixed in 2% osmium tetroxide in 
cacodylate buffer and dehydrated through a series of 50%, 70% and 90% (v/v) 
methanol for 10 minutes in each solution, and a further 30 minutes dehydration. All 
the solutions used in processing the specimens (from the wash after glutaraldehyde 
fixation to dehydration with 70% (v/v) methanol) contained 0.05% (v/v) ruthenium 
red. The samples were then infiltrated in equal parts of absolute alcohol and Spurns 
resin for one hour. One part absolute alcohol and 3 parts Spurns resin were infiltrated 
overnight. 
Three fresh changes of 100% resin were made throughout the day and then the 
sample was embedded in fresh resin in correctly labelled capsules. These were left in 
the oven at 60°C to polymerise overnight. 500nm sections of each block were cut on a 
Reichert Ultracut S microtome and these were mounted onto glass slides. These, so 
called semi-thin sections were stained with a 1% toluidine blue in 1% borax solution 
and examined on a light microscope to select appropriate areas for electron 
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microscope review. Sections of the selected blocks were cut at a thickness of 
approximately 100nm and mounted onto copper grids, stained with 10% (v/v) uranyl 
acetate for 20 minutes, washed in multiple changes of distilled water followed by 
staining in 0.1% (v/v) lead citrate (Reynolds, 1963) and further washes in distilled 
water. When the sections were completely dry, they were viewed under a JEOL 
1 OOCX Transmission Electron Microscope and electron micrographs were produced. 
2.9 Screening for bacteriophages and bacteriocin producers 
Stools specimens were initially screened for bacteriophages in the hope of identifying 
a phage that might have potential therapeutic effects in recalcitrant infections. Faecal 
specimens from multiple sources (farm sewage, goat, sheep, rabbit, cow, and horse) 
were each suspended in l Oml of Ringefs' solution and were centrifuged (Jouan 
Centrifuge, St Herblain, France). 0.5% (v/v)and 0.75 % (v/v) BHI sloppy agars were 
maintained in liquid form in a 50°C water bath. To 3mL of a sloppy agar, 1 mL of 
each faecal supernatant and 3 drops of an overnight broth of C. docile were added 
and gently mixed before pouring over a BHI agar plate (1.5%). Plates were then 
incubated anaerobically for 24 hours and then examined for any lytic effects. No 
phage plaques were detected. However, clearings around suspected colonies with 
bacteriocin-like activity against C. difcile were observed. Suspect bacteriocin- 
producers were subcultured onto Colombia blood agar. Further identification was 
then carried out by Gram staining latex agglutination testing (Oxoid) and by an API 
20 Strep (bioMerieux sa, Marcy-l'Etoile/France). Reference laboratory facilities 
(CPHL, Colindale, UK) were also used. 
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Chapter Three 
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3.1 Introduction 
As noted in Chapter One, Clostridium dill cile, being associated with antibiotic- 
associated diarrhoea, is a major public health concern, especially in hospitalised 
elderly patients (CDSC, 2000). The overuse of antibiotics that predispose to selection 
of the organism is well recognised (Gorbach, 1999). Contamination of the ward 
environment with spores of this clostridium, and the difficulty with eradication, 
highlight the importance of C. difcile as an infection control issue (Savage and 
Alford, 1983). It is recognised that most bacteria are likely to exist in nature within 
biofilms, a situation that will also include many organisms resident in the human 
body. MacFarlane et al. (1997) discuss growth of organisms in biofilm in the 
gastrointestinal tract. The human colonic ecosystem is an extremely complex 
environment comprised of several hundred different strains of bacteria. Their studies 
were undertaken to determine whether these colonic organisms formed metabolic or 
genotypically distinct assemblages in the gut microbiota in relation to polysaccharide 
fermentation. They showed communities of polymer-degrading bacteria and other 
groups of intestinal anaerobes growing on particulate matter that were essentially 
similar to those occurring elsewhere in the gut lumen. 
As there is no previous report of an anaerobe being investigated in a biofilm mode of 
growth in the laboratory, the first aim of this work was to determine the growth 
characteristics of C. docile using the Sorbarod filter system (Struthers, 2000). 
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3.2 The growth of Clostridium difficile in broth culture and biofilm 
The growth patterns of the clinical strain of C. d cile in broth culture, and on 
Sorbarod filters, in the biofilm mode of growth, are shown in Figs. 4 (broth) and 5,6, 
7 (filters). In broth culture, maximum titres of about 108 cfu/mL were reached within 
24 hours. There was a drop of about 1 log. after this period, but the titre then 
remained stable for at least a further 48 hours. As discussed later, this stable titre was 
probably due to this clinical isolate sporulating at high frequency. In the filters, the 
titres were maintained for at least 96 hours, with values of>109 cfu/mL being 
achieved. The titre in the filter effluent was in the order of 1 log. lower in most 
circumstances. There was little variation in the titre in the filters when different 
speeds were used to deliver the feed broth to the filters. The speed of the pump at 4 
rpm equated to a flow rate of about 4 mL/hour, and this speed was used for 
subsequent experiments. The filters did begin to block from 72h - 96h. 
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Fig. 4 Growth curve of C. docile (A) in broth culture 
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Fig. 5 Growth curve of C. difficile; feedbroth of BHI pumped at 2 rpm. Biofilm 
effluent titres cfu/mL ( f) and biofilm titres cfu/filter ( ) 
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Fig. 6. Growth curve of C. difficile; feedbroth of BHI pumped at 4 rpm. Biofilm 
effluent titres cfu/mL ( f) and biofilm titres cfu/filter (  ) 
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Fig. 7 Growth curve of C. difficile; feedbroth of BHI pumped at 6 rpm. Biofilm 
effluent titres cfu/mL (f ) and biofilm titres cfu/filter (  ) 
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3.3 Light microscopic studies of C. difcile 
Light microscopy studies revealed several features of the organism, depending on the 
growth medium used. In broth culture less than 24h in age, the typical rod-shaped 
structure of the bacterium was seen (Fig. 8). There was some degree of pleomorphism 
here, with variation in organism length between 1.8 and 4.5g. By 48h, sporulating 
bacteria could be identified (Fig. 9). On blood agar plates C. dijficile likewise 
exhibited the typical rod-shaped structure (Fig. 10). Here again there was some 
degree of pleomorphism, with the length of organisms varying from 1.2 to 4.5µ. By 
72h, the majority of bacteria had sporulated (Figs. 11,12). 
In biofilm, the bacteria often exhibited a filamentous structure, which were 
occasionally curled (Fig. 13). The length of the organisms was often in excess of 10 
microns. Sporulation was rarely observed. 
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Fig. 8 Gram stain of broth culture at 24h (Scale: 1 µm = 4mm) 
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Fig. 9 Spore stain of C. difficile broth culture at 48h showing spores 
(A). (Scale: 1µm = 4mm) 
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Fig. 10 Gram stain of C. difcile from blood agar plate day 1 showing pleomorphic 
Gram-positive rods. (Scale: 1 µm = 4mm) 
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Fig. 11 Gram stain of C. difficile from blood agar plate day 3. 
(Scale: 1 µm = 4mm) 
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Fig. 12 Gram stain of C. difficile from blood agar plate day 8. 
(Scale: 1 µm= 4mm) 
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Fig. 13 Gram stain of C. difficile from 48h biofilm. (Scale: 1µm = 4mm) 
79 
3.4 Electron Microscopy 
Transmission electron microscopy studies of the organism in broth, plate and biofilm 
culture are shown in Figs. 14- 25 . In broth culture at 24 hours, occasional spores 
were identified (Fig. 14), and by 48 hours this was a relatively common event (Fig. 
15). On plates, at 24 hours, the typical rod-shaped structure of the organism was 
evident (Fig. 16), and some degree of sporulation was already evident (Fig. 17). 
Spores and spore formation showed the typical features of bacterial spores (Figs. 
18,19,20), and at higher magnification, the typical layers of the spore were readily 
identified (Fig. 21). These were identified as the inner membrane (A), inner dense 
cortical layer (B), outer less dense cortical layer (C), inner coat (D), outer coat (E) 
and exosporium (F) (Joklik et. al., 1988). At 48 hours on the plates, the majority of 
organisms existed as spores (Fig. 22). In the filters, sporulation was not observed to 
any extent. (Fig. 23), and where elongated forms were identified by electron 
microscopy (Fig. 24), it was probable that these structures were due to non-separation 
of the bacteria at cell division (Fig. 25). 
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Fig. 14 Electron micrograph of broth culture at 24h showing occasional spores (see 
arrow 7). (Scale: 1 µm = 7mm) 
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Fig. 15 48h broth culture of C. difficile showing numerous spores (see arrow I ). 
(Scale: 1 µm = 7mm) 
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Fig. 16 The classic rod-shape structure of C. difficile from a 24h blood agar plate 
culture. (Scale: 1µm = 35mm) 
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Fig. 17 Sporulation of C. difficile from 24h blood agar plates (see arrows Y). 
(Scale: I µm = 7mm) 
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Fig. 18 Typical features of C. difficile spores at 24h from blood agar plates. 
(Scale: 1µm = 14mm) 
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Fig. 19 Higher magnification of C. difcile spores from 24h blood agar plates. 
(Scale: 1µm= 25mm) 
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Fig. 20 Spore structure of C. difficile from 24h blood agar plate. (Scale: 1µm = 
25mm) 
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Fig. 21 The typical layers of a spore from a 24h blood agar plate; the inner membrane 
(A), inner dense cortical layer (B), outer dense cortical layer (C), inner coat 
(D), outer coat (E) and exospori um (F). (Scale 0.1micron= 10mm) 
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Fig. 22 Electron micrograph of 48h culture of C. difficile on blood agar plates 
showing numerous spores. (Scale 1 µm = 14mm) 
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Fig. 23 Electron micrograph of C. difficile grown in biofilm for 48h. Sporulation was 
rarely observed. (Scale I µm= 7mm) 
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Fig. 24 Elongated filamentous structures of C. diJcile when grown in biofilm 
(here at 48h). (Scale I µm = 14mm) 
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Fig. 25 Higher magnification of the filamentous structures of C. diJcile in biofilm at 
48h. It is probable that there was non-separation of the bacteria at cell- 
division. (Scale 0.5µm = 36mm) 
92 
3.5 Characterisation of Toxins (A and B) production by C. difficile in broth and 
biofilm 
C. dicile produces 2 major exotoxins that cause diarrhoea and colitis (Borriello et 
al., 1990). Toxin A causes fluid secretion, mucosal damage and inflammation and 
toxin B acts as a cytotoxin (Pothoukalis, 1996). As previously mentioned, toxin 
determination in stool specimens was the initial observation that led to the discovery 
of C. difcile being responsible for AAD (Larson et al., 1977). The detection of 
cytotoxin in faecal tissue by culture is considered "the gold standard" (Groschel et al., 
1996), however commercial enzyme immunoassays are more widely used because of 
their good specificity, rapid turnaround time, convenience and cost (Lyerly et al., 
1998). It is known that organisms in the biofilm mode of growth can exhibit an 
altered phenotype with respect to growth rate and transcription (Donlan and 
Costerton, 2002). The Sorbarod filter system was used to compare expression of 
toxins in biofilm with that found in broth culture of C. docile. Toxin activity was 
determined using the Ridascreen® Clostridium docile toxin AB enzyme 
immunoassay as described in Chapter 2. 
Toxin levels in the clarified supernatants obtained from growing C. dicile in broth, 
biofiim and biofilm effluent are shown in Fig. 26. Between 24 and 48 hours on the 
filter, the amount of toxin reached the maximum detectable by the Ridascreen 
method. The amount of toxin detected in broth and biofilm effluent was consistently 
of lower value. 
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Fig. 26 Comparison of the toxin activity of Clostridium difficile in broth (A), biofilm 
effluent (") and biofilm ( ) over 72h. 
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3.6 Discussion 
The aim of this chapter was to determine whether Sorbarod filters could be used to 
produce a model biofilm system for studying C. diJcile. Using a clinical isolate, the 
typical features of the organism were shown in broth and plate culture, with the usual 
rod-shaped structure of vegetative bacteria being evident. While spores could be seen 
at 24 hours, by 48 hours they were a common feature with this isolate. High powered 
electron micrographs showed that these spores had the features typical of bacterial 
spores. In broth culture, the organism reached a maximum titre at about 24 hours. 
Titres were maintained at a similar level after this period; presumably this was due to 
the formation of spores, which germinated on titration. A degree of pleomorphism in 
the vegetative organisms was noted here with the length varying from 1.2 to 4.5 
microns. Such pleomorphism is a recognised feature of clostridia (Hathaway and 
Johnson, 1998). 
In biofilm, C. dicile maintained its titre in excess of 109 cfu/mL for at least 96 
hours, in a steady state. The concentration of the organism in the biofilm effluent was 
of the order of 1 log. lower than that in the filter at the corresponding time. In the 
filters, the organism often showed elongated forms in excess of 10 microns in length, 
and on occasion these were seen as short spirals. While no readily identified 
difference in the cell wall structure of bacteria grown in the filters, broth or plate were 
seen, in the filter, C. docile also exhibited a "Gram-negative" appearance on 
occasion. Studies of thin sections of filters fixed by standard histopathological 
methods, section and Gram-stained have shown irregular microcolonies of bacteria 
varying from 10-50 microns in width, which were adherent to the cellulose fibres of 
the filters (O'Connell et. al, 2003). It is therefore considered reasonable to conclude 
that on the Sorbarod filters that the organism can establish itself in continuous culture 
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for at least 96h, by which time the filters did begin to block. The lack of sporulation 
in this system confirmed that vegetative growth was being maintained. Simple 
experiments on the toxin titre showed that high concentrations of toxin were 
maintained up to at least 96h. It would appear that there are definite differences in 
toxin synthesis when the biofilm system is compared to broth and biofilm effluent. 
This work thus established the experimental conditions for the antibiotic experiments 
in the next chapter, where the susceptibility of the organism in standard broth culture 
MIC and MBC experiments were compared with the antibiotic sensitivity profile in 
the biofilm mode of growth in the Sorbarod filters. 
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Chapter Four 
97 
4.1 Introduction 
Enteral metronidazole and vancomycin are the mainstays of treatment of C. docile 
infection and combination therapy with rifampicin has also shown good clinical 
response (Wilcox and Spencer, 1992; Buggy, 1993). Antimicrobial susceptibility 
testing of C. dicile is not routinely performed in most laboratories. The reference 
method for susceptibility testing is the agar dilution method (www. BSAC. org ; 
NCCLS, 1997), but it is considered both too time-consuming and labour intensive to 
be a routine test. Minimum inhibitory concentrations (MIC) of clostridial species are 
documented. For C. perfringens the penicillin MIC range is 0.06-0.25 mg/L, for C. 
dicile, the vancomycin MIC range is 1-8mg/L and that for metronidazole is 0.25- 
0.5 mg/L (Kucers and Bennett, 1987). C. docile is also very sensitive to rifampicin. 
There are no minimum bactericidal concentrations (MBC) of these antibiotics to C. 
docile documented in the literature. The aim of this work presented in this chapter 
was thus to compare the tube MIC/MBC results with that of the clinical strain grown 
in the Sorbarod filters. 
4.2 The determination of the tube MIC/MBC, BEC and EIMBC 
In initial experiments, the clinical isolate of C. docile (459) and the NCTC strain 
11204 (Type) were used. Benzylpenicillin, vancomycin, metronidazole and 
rifampicin were the antibiotics tested. The initial MIC/MBCresults are summarised in 
Tables 6 and 7. For the first three antibiotics tested, the MIC values were close to 
those published (Kucers and Bennet, 1987; Wilcox and Spencer, 1992; Buggy, 1993). 
With the exception of rifampicin, the other antibiotics showed that there was 
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significant degree of tolerance in the MBC experiments. The MBC for rifampicin was 
0.25 mg/L, which is within the "sensitive" range. For the other antibiotics the MBC 
values were above 32 mg/L. In further experiments with the four antibiotics and the 
NCTC strain plus five clinical isolates, MIC/MBC experiments were conducted to 
128 mg/L, and with the exception of rifampicin, tolerance was identified (Table 3). 
With metronidazole an endpoint between 8-128mg/Lwas reached for 4 clinical 
isolates in the range of concentrations tested. 
The results of a BEC and EfMBC experiment controlled by a tube MIC are shown in 
Table 8. Here again with benzylpenicillin, vancomycin and metronidazole tolerance 
was noted on both the filter and in the effluent. With rifampicin a BEC of 8mg/L and 
EfMBC of 1. Omg/L was determined. This mirrored the effect in broth. In repeat 
experiments with rifampicin, some degree of variability in the susceptibility was 
noted in that tolerance was demonstrated in the filters, but in all cases the organism 
was eliminated from effluent at concentrations of 1-4mg/L. 
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'rubenIfC Etest iiir 
Benzylpenicillin 4.0 1.0 >32 
Vancomycin 2.0 1.0 >32 
Metronidazole 0.5 0.25 >32 
Rifampicin 0.004 <0.002 0.25 
Table 6 Results of tube MIC/MBC of clinical strain 459 with benzylpenicillin, 
vancomycin, metronidazole and rifampicin. (Values in mg/L) 
MR ki I ftS 
Benzylpenicillin 1 >128 
Vancomycin 2 >128 
Metronidazole 0.5 64 
Rifampicin <0.004 0.25 
Table 7 Results of tube MIC/MBC of NCTC C. difficile strain with benzylpenicillin, 
vancomycin, metronidazole and rifampicin. (Values in mg/L) 
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N11C IBC 
Vancomycin 
2302 
1342 
459 
2236 
TYPE 
1790 
Metronidazole 
1 
1 
2 
0.5 
2 
1 
>128 
>128 
>128 
>128 
>128 
>128 
2302 0.128 32 
1342 0.25 8 
459 0.5 64 
2236 0.25 >128 
TYPE 0.5 64 
1790 1 128 
Penicillin 
2302 2 >128 
1342 1 >128 
459 4 >128 
2236 2 >128 
TYPE 1 >128 
1790 2 >128 
Rifampicin 
2302 <0.004 1 
1342 <0.004 1 
459 0.004 0.25 
2236 <0.004 1 
TYPE <0.004 0.25 
1790 0.016 1 
Table 8 Tube MIC and MBC values of clinical strains of C. dicile and the type 
NCTC strain. 
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Benzylpenicillin >32 >32 
Metronidazole >32 >32 
Vancomycin >32 >32 
Rifampicin 8.0 1.0 
Table 9 Biofilm eradicating concentration (BEC) and biofilm effluent (EfMBC) of 
wild strain (clinical isolate 459) using benzylpenicillin, vancomycin, 
metronidazole and rifampicin. (Values in mg/L). A control tube MIC was 
done here for each antibiotic. 
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4.3 The features of antibiotic susceptibility on the Sorbarod filters 
With the four antibiotics used, each filter and effluent which had been exposed to one 
concentration of the agent for 18 hours, was titred, along with the antibiotic free 
control. A tube MIC experiment was run in conjunction with each filter experiment. 
The results of duplicate experiments are shown in Figs. 27-34. For benzylpenicillin 
(Figs. 27,28), vancomycin (Figs. 29,30) and metronidazole (Figs. 31,32), while there 
was some fluctuation in the titre of the organism in the filters, the bacteria were 
present in high titres up to a concentration of 32 mg/L. In the case of the biofilm 
effluent, there was wider fluctuation, and a significantly lower titre, however the 
organism was still present in effluent at 32 mg/L. Representative experiments with 
rifampicin, are shown in Figs. '33,34. With this antibiotic a discernable end point was 
achieved in the effluent (1-4 mg/L), and an endpoint was also achieved with one BEC 
experiment (Fig. 33). 
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Fig. 27 Effect of penicillin on growth of C. difficile on Sorbarod biofilm. Individual 
biofilms were exposed to single concentration of antibiotic for 18h; after 
collection of effluent, biofilm was harvested. Titres were done as described in 
the text to determine BEC and effluent MBC. Effluent titres; cfu/mL 
(f) and biofilm titres; cfu/filter ( ). 
104 
10 - 
3 
2 
1 
0 
0 0.125 0.25 0.5 1248 16 32 
mg/1L 
Fig. 28 Repeat experiment - effect of penicillin on growth of C. difficile in biofilm 
Effluent titres; cfu/mL (f) and biofilm titres; cfu/filter (  ). 
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Fig. 29 Effect of vancomycin on growth of C. difcile on Sorbarod biofilm. 
Individual biofilms were exposed to single concentration of antibiotic for 18h; 
after collection of effluent, biofilm was harvested. Titres were done as 
described in the text to determine BEC and effluent MBC. 
Effluent titres; cfu/mL (f) and biofilm titres; cfu/filter (  ). 
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Fig. 30 Repeat experiment - effect of vancomycin in biofilm. 
Effluent titres; cfu/mL (f) and biofilm titres; cfu/filter ( ). 
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Fig. 31 Effect of metronidazole on growth of C. difficile on Sorbarod biofilm. 
Individual biofilms were exposed to single concentration of antibiotic for 18h; 
after collection of effluent, biofilm was harvested. Titres were done as 
described in the text to determine BEC and effluent MBC. Effluent titres; 
cfu/mL (f) and biofilm titres; cfu/filter (  ). 
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Fig. 32 Repeat experiment - effect of metronidazole on growth of C. 
dicile in biofilm. Effluent titres; cfu/mL (f) and biofilm titres; 
cfu/filter ( ). 
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Fig. 33 Effect of rifampicin on growth of C. difficile on Sorbarod biofilm. Individual 
biofilms were exposed to single concentration of antibiotic for 18h; after 
collection of effluent, biofilm was harvested. Titres were done as described in 
the text to determine BEC and effluent MBC. Effluent titres; cfu/mL (f ) 
and biofilm titres; cfu/filter ( ). 
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Fig. 34 Repeat experiment - effect of rifampicin on growth of C. diJcile in 
biofilm. Effluent titres; cfu/filter (f) and biofilm titres; cfu/filter (  ). 
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4.4 The effect of high concentration of vancomycin alone or combined with fixed 
concentrations of rifampicin. 
Filter and effluent experiments were conducted where the organism was exposed to 
vancomycin at concentrations up to 256 mg/L. These are shown in Figs. 35 and 36. 
Here again C. docile was resistant to this antibiotic at these very high 
concentrations. The results of combining vancomycin over the same concentration 
range with rifampicin at 1 or 8 mg/L are shown in Figs. 37 and 38 respectively. This 
identifies a form of synergy between the two antibiotics, with a discerned killing 
effect with rifampicin at a fixed concentration. For Img/L of rifampicin, the organism 
was eliminated at 128mg/L of vancomycin in both the biofilm and effluent. For 
8mg/L the organism was eliminated at 32mg/L of vancomycin. 
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Fig. 35 Effect of high concentration of vancomycin on growth of C. difficile in 
biofilm. Effluent titre; cfu/filter (") and biofilm titre; cfu/filter ( ). 
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Fig. 36 Repeat experiment of effect of high concentration of vancomycin on 
C. difficile in biofilm. Effluent titre; cfu/filter (") and biofilm titre; cfu/filter 
("). 
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Fig. 37 Effect of rifampicin (lmg/L) + differing vancomycin concentrations on 
growth of C. docile in biofilm. Effluent titre; cfu/filter (") and biofilm 
titre; cfulfilter (M). 
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Fig. 38 Effect of combination of rifampicin (8mg/L) + differing vancomycin 
concentrations on growth of C. difficile in biofilm. Effluent titre; cfu/filter (f ) 
and biofilm titre; cfu/filter ( ). 
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4.5 The effect of antibiotics on toxin production by C. difficile in 
bioslm 
Following antimicrobial susceptibility testing of C. docile in biofilm, effluents and 
vortexed filters were centrifuged for each antibiotic, at differing concentrations, in 
duplicate. Toxin activity was determined, as previously described in Chapter 2. 
In general, toxin activity was always present in biofilm for all antibiotics. Absorbance 
values were maximum at the lowest concentration of antibiotic. This contrasts with 
toxin activity for biofilm effluents, although absorbance measured was lesser in 
value, activity appeared to increase when antibiotic concentrations increased. 
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Fig. 39 Effect of vancomycin on toxin production of C. difficile in biofilm. 
Absorbance values of biofilm effluent (" ) and biofilm ( ). 
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Fig. 40 Effect of vancomycin on toxin production of C. difficile in biofilm. 
Absorbance values of biofilm effluent (" ) and biofilm ( ). 
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Fig. 41 Effect of metronidazole on toxin production of C. diffacile in biofilm. 
Absorbance values of biofilm effluent (" ) and biofilm ( ). 
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Fig. 42 Effect of metronidazole on toxin production of C. difficile in biofilm. 
Absorbance values of biofilm effluent (" ) and biofilm ("). 
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Fig. 43 Effect of penicillin on toxin production of C. difficile in biofilm. Absorbance 
values ofbiofilm effluent (" ) and biofilm ( ). 
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Fig. 44 Effect of penicillin on toxin production of C. diJcile in biofilm. Absorbance 
values of biofilm effluent (") and biofilm ( ). 
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Fig. 45 Effect of rifampicin on toxin production of C. difficile in biofilm. 
Absorbance values of biofilm effluent (" ) and biofilm ( ). 
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Fig. 46 Effect of rifampicin on toxin production of C. difficile in biofilm. 
Absorbance values of biofilm effluent (") and biofilm ( ). 
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4.6 Discussion 
The MIC values of both the clinical and ATCC strains of C. docile to 
benzylpenicillin, vancomycin and metronidazole correlated with the MIC values in 
the literature (Kucers and Bennett, 1987). However a high degree of tolerance, 
usually in excess of 128 mg/L, was identified in the tube MBC. This feature was 
mirrored in the Sorbarod filter experiments with these antibiotics, reflecting the 
accepted resistance to antibiotics in a biofilm system (Gander, 1996; Struthers, 2000). 
The tolerance in the biofilm effluent reflected that reported previously with other 
organisms (Muli and Struthers, 1998; Struthers, 2000). It should be noted that when 
bacteria from the filters and effluent were plated onto agar and examined directly by 
disc and Etest methods, that the bacteria had reverted to the sensitive phenotype. 
With rifampicin, the MIC confirmed the susceptibility of C. difcile to this agent, and 
a MBC value of 0.25 to 1.0 mg/L was obtained. In the Sorbarod filters, the effluent 
MBC varied from 1-4 mg/L, and in at least one experiment, controlled by a tube MIC 
experiment, a BEC of 8 mg/L was obtained. This showed that rifampicin appeared to 
have significantly better bacteriocidal activity against the organism when it was in 
broth, as a biofilm in the filters, or in filter effluent, than the other three agents. 
Further experiments showed that tolerance to vancomycin occurred in the filters and 
effluent up to 256 mg/L at least, but with the addition of rifampicin at appropriate 
pharmacokinetic levels, significant synergistic killing was achieved in the filter 
system. 
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With benzylpenicillin, metronidazole and rifampicin, conducting experiments with 
concentrations of up to 32 mg/L are appropriate, as the range up to this value relates 
to the pharmacokinetics of these agents in the human (Kucers and Bennett, 1987). 
With vancomycin, the situation is different, for via the oral route, it is poorly 
absorbed, and high concentrations, in the order of 200-300 mg/L are obtained in the 
colonic fluid (Kucers and Bennett, 1987). The tolerance of the C. dicile to three of 
the agents in the filters and effluent could be of relevance to the treatment of CDAD. 
It may be reasonable to assume that the addition of rifampicin to vancomycin, based 
on the work here, could have a clinical basis to it, considering that vancomycin 
achieves high concentrations in the colon, and noting the report that the combination 
of vancomycin and rifampicin is effective in treatment (Buggy, 1993). 
As discussed in chapter 3, the testing of toxin by the EIA did have a degree of 
variability associated with it, and this is reflected in the toxin experiments done here. 
It is worthwhile to note that at the lower antibiotic concentrations, that the level of 
toxin was consistently lower in the effluent than that in the filter. This to an extent 
may reflect the difference in the titres of organisms in the two circumstances, but it 
may be that there is some control process in the biofilm form of growth. In two 
experiments (Figs. 42 and 43), the maximum toxin levels were maintained up to 32 
mg/L in the filters. 
This work laid the basis for the next chapter, where the growth of C. difcile in 
biofilm was investigated in combination with other common bowel bacteria, and the 
effect of several antibiotics was investigated. 
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Chapter Five 
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5.1 Introduction 
The colon harbors approximately 1011 organisms per mL of fluid and bacteria account 
for 30% of faecal dry weight (Reese and Betts, 1996). More than 400 different 
species of bacteria can be found in a single faecal specimen. The bacterial flora of the 
gastrointestinal tract has been the subject of investigation for many years. This is a 
site of proliferation of a large number of species of micro-organisms, with domination 
of different strains being influenced by many factors, and competition and 
interference being widespread (Reid et al., 1990). Some gastrointestinal tract studies 
have focused on bacterial interactions and their impact on anatomic, physiologic, and 
immunologic parameters of the colon (Rolfe, 1984). Antagonisitic and co-operative 
reactions, which lead to interference in the establishment of pathogenic organisms, 
are known to occur. This process, whereby the microflora resists incursion by harmful 
microorganisms, has been referred to as colonization resistance (Reese and Betts, 
1996). 
Maintenance of a normal bowel ecosystem is one of the main defences against C 
d jJcile colonization (Borriello, 1998). Almost any antibiotic may cause C. d jJcile 
disease, but broad-spectrum antibiotics allow C. d jflcile to become established in the 
bowel (Gorbach, 1999). It has been shown previously that two organisms can be 
grown together on Sorbarod filters (Muli and Struthers, 1998; Budhani and Struthers, 
1999). In the case of S. pneumoniae and Moraxella catarrhalis, both organisms 
maintained similar titres on the biofilms (Budhani and Struthers, 1999). The Sorbarod 
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filter system was used here to investigate the growth of C. dicile in combination 
with recognized members of the bowel flora and included Bacteroides fragilis, 
Enterococcus faecalis and Escherichia coll. 
Human and animal stool specimens were screened for bacteriophage and bacteriocin 
activity against C. docile, and if such activity were identified, some basic 
investigations were to be conducted. The aim of the chapter was to use the Sorbarod 
filter system as an investigative procedure for combinations of C. dicile with other 
bowel bacteria. 
5.2 Growth of Bacteroidesfragilis, Enterococcusfaecalis and 
Escherichia coli in biofilm 
Initially, before combination experiments could be considered, it was important to 
establish if B. fragilis, E. faecalis and E. coli could readily grow as single organisms 
in biofilm on the Sorbarod filters. Growth of each organism could be achieved in this 
biofilm model and was also maintained for up to 72h. 
B. fragilis reached biofilm titres in excess of 1010 cfu/filter (Figs. 47,48). The titre of 
the B. fragilis effluent was in the order of 1-3 log. lower. E. faecalis reached high 
biofilm titres of up to 1011 cfu/filter (Figs. 49,50). Again, the effluent for this 
organism was of the order of 1-2 log. lower. Similarly, E. coli sustained growth for 
72 h on the filters with titres in excess of 109 cfu/filter (Figs. 51,52). 
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Fig. 47 Growth of B. fragilis in biofilm. Effluent titres (f) and biofilm titres (9). 
131 
121 
10 
8 
ý 
ý U 
ý 
ý 
0 
J 
4- 
2 
Oh 24h 48h 72h 
Time 
Fig. 48 Repeat experiment of growth of B. fragilis in biofilm. Effluent titres (f) 
and biofilm titres ("). 
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Fig. 49 Growth curve of E. faecalis in biofilm. Effluent titres (f) and biofilm titres 
(. ). 
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Fig. 50 Growth curve of E. faecalis in biofilm. Effluent titres (f) and biofilm titres 
("). 
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Fig. 51 Growth curve of E. coli in biofilm. Effluent titres (f) and biofilm titres (" ). 
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Fig. 52 Growth curve of E. coli in biofilm. Effluent titres (f) and biofilm titres ("). 
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5.3 Selective media for combination experiments 
In order that organisms could be selectively isolated from combination growth 
experiments, selective media needed to be developed. The combination experiments 
involved growth of C. dicile with either B. fragilis, E. faecalis or E. coll. Table 10 
summarises both the atmospheric conditions and antibiotic susceptibilities of the 
organisms. Both E. faecalis and E. coli could be selected by growth on agar plates 
under aerobic conditions at 37°C. Trimethoprim was added to BHI agar plates to 
select for C. . 
ricile when grown with E. faecalis. Gentamicin was added to BHI agar 
plates to select for C. di/cile when grown with E. coll. When C. docile and B. 
fragilis were grown together, aztreonam and vancomycin were used to select out the 
respective organism. 
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C difficile E. facýcalis E. coli B. fraqilis 
Aerobic X NOO v x 
Anaerobic wo VO vp 
Vancomycin xXv 
Aztreonam %0 vxX 
Trimethoprim V, xv. Iwo 
Gentamicin X %0 
Table 10 Conditions used for selection of each organism in dual 
organism biofilm experiments. (v = growth of organism, 
X= inhibition of growth) 
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5.4 Combination experiments of B. fragilis, E. faecalis and E. coli in 
biofilm. 
The results of combination experiments in the Sorbarod filters are shown in Figs. 53, 
54 (C. difficile and B. fragilis), 55 (C. dicile and E. faecalis), 56,57 (C. docile and 
E. coli). To an extent, the titres in the filters mirrored those of the organisms grown 
individually. 
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Fig. 53 Growth curve of C. difficile with B. fragilis in biofilm. C. difficile effluent 
titres (+) and biofilm titres ( ); B. fragilis effluent titres (f) and 
biofilm titres (" ). 
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Fig. 54 Growth curve of C. diJcile with B. fragilis in biofilm. C. difficile effluent 
titres (") and biofilm titres ( ); B. fragilis effluent titres (f) and biofilm 
titres (" ). 
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Fig. 55 Growth curve of C. dijcile and E. faecalis in combination. C. difcile 
effluent titres (") and biofilm titres ( ); E. faecalis effluent titres (f) 
and biofilm titres ("). 
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Fig. 56 Growth curve of C. difcile and E. coli in combination. C. difficile effluent 
titres (+) and biofilm titres ( ); E. coli effluent titres (f) and biofilm titres 
(")" 
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Fig. 57 Growth curve of C. difficile in combination with E. coli. C. difficile effluent 
titres (") and biofilm titres ( ); E. coli effluent titres (f) and biofilm titres 
(" ). 
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5.5 Antimicrobial susceptibility testing of C. difficile and E. coli in 
biofilm 
The administration of antibiotics is considered the most significant predisposing 
factor for C. ditcile infection. Although any antibiotic can potentially cause C. 
docile disease, broad-spectrum antibiotics against enteric organisms are considered 
the main predisposing agents. Two broad-spectrum antibiotics, co-amoxiclav and 
meropenem were used against a combination of C. docile and E. coli grown in 
biofilm on Sorbarod filters. The MIC of both organisms for co-amoxiclav and 
meropenem was determined by the Etest (Table 11). 
The results for experiments with co-amoxiclav and meropenem are shown in Figs. 58, 
59 and 60,61 respectively. While there was a degree of variation in the titres, both 
organisms maintained their titres up to at least 32mg/L. The exception was the repeat 
co-amoxiclav experiment, where C. docile, at a lower starting titre of 106 cfu/mL, 
was eliminated from the effluent and biofilm at 32mg/L. 
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Co-amoxiclav 
MIC mg/L 
Meropenem 
MIC mg/L 
C. dicile 459 0.125 0.38 
E. coli 0.023 4 
Table 11 Etest determination of MIC of C. difcile and E. coli to co-amoxiclav and 
meropenem 
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Fig. 58 Effect of co-amoxiclav on growth of both C. difficile and E. coli in biofilm. 
C. difcile effluent titres (") and biofilm titres ( ); E. coli effluent titres 
(f ) and biofilm titres ("). 
147 
128 
12 ý 
z w V 
O 
aý O 
J 
[co-amoxiclav] mg/L 
Fig. 59 Effect of co-amoxiclav on growth of C. difficile and E. coli in biofilm. 
C. difficile effluent titres (") and biofilm titres ( ); E. coli effluent titres 
). (f) and biofilm titres ( 
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Fig. 60 Effect of meropenem on growth of C. diJcile and E. coli in biofilm. 
C. difficile effluent titres (") and biofilm titres(   ); E. coli effluent titres 
(f ) and biofilm titres (9). 
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Fig. 61 Effect of meropenem on growth of C. diJcile and E. coli in biofilm. 
C. difcile effluent titres (") and biofilm titres ( ); E. coli effluent titres 
(f) and biofilm titres (9). 
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5.6 Screening for bacteriophage and bacteriocin-producing 
microorganisms 
Stool specimens from human, goat, cow and horse sources as well as sewage effluent 
samples, obtained from the outflow at the Coventry Sewage Works, were screened for 
the presence of bacteriophage and bacteriocin-producing micro-organisms. Typical 
bacteriophage plaques were not noted, however "clearing zones" were observed in the 
C. docile lawn when the horse faecal specimen was screened (Fig. 62). 
5.7 Characterisation of a bacteriocin producing micro-organism 
Small orange colonies were noted in the centre of the clearing zones or plaques (Fig. 
62). The orange colonies were subcultured onto blood agar plates which were 
incubated aerobically and anaerobically at 37°C. The organism grew in both 
atmospheric conditions and staining revealed a Gram-positive coccus in chains. API 
strep 20 profiling identified that this isolate was Streptococcus uberis (99.9% 
certainty). However, the isolate was referred to the Streptococcus Reference 
Laboratory at Colindale for confirmation. The isolate in fact proved to be 
Lactobacillus paracasei. 
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Fig. 62 Photograph of clearings zones on C. difficile- enriched BHI agar plate around 
small orange colonies 
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5.8 Bacteriocin from Lactobacillus paracasei: determination of 
spectrum of activity 
There have been many studies of bacterial antagonism since this phenomenon was 
reported originally by Pasteur and Joubert (1877). Characterisation of the spectrum of 
activity of the bacteriocin from L. paracasei was undertaken. A modification of the 
method described by Gillies and Govan (1966) was initially used. Streaks of L. 
paracasei were made centrally onto blood agar plates. Test organisms were 
inoculated in perpendicular streaks to L. paracasei. Zones of inhibition for the test 
isolates were noted. Table 11 shows the spectrum of activity of the bacteriocin against 
various isolates. It appeared to have an inhibitory effect on the growth of C. docile, 
S. pneumoniae and B. cereus. Fig. 63 is a photographic representation of the zones of 
inhibition of the bacteriocin to C. difcile and S. pneumoniae. 
Further characterization of this bacteriocin's activity against other clostridial strains 
was undertaken using both a modification of Gilles and Govan (1966) (Table 12), and 
a modification of the method described in Chapter 2 for the screening for 
bacteriophage / bacteriocins. A suspension of L. paracasei was made in Ringer's 
solution (McFarland 0.5) and serial dilutions to 10-6 were done. One hundred µL of 
each dilution of L. paracasei was added to 3mL of sloppy agar plus 1mL of overnight 
broth of each clostridial strain. Activity was demonstrated by zones of inhibition to C. 
dicile strains, C. tetani, C. bifermentans and C. novyi. Titres ofL. paracasei were 
determined in experiments against S. pneumoniae, NCTC C. docile and the clinical 
strain 459. Titres were between 2- 4x 108 cfu/mL. 
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Bacteriocin effect 
Listeria mono to enes x 
S. aureus x 
Staphylococcus e idermidis x 
E. aecalis X 
Bacteroides ra ilis X 
E. coli X 
C. e rtn ens X 
C. dt icile 459 %0 
Type C. difficile v 
C. di ccile 2302 VO 
C. dt icile 1462 WO 
C. dt icile 2223 v 
Streptococcus neumoniae 
Bacillus cereus 
Haemophilus influenzae x 
Neisseria lactima x 
Salmonella poona x 
Pseudomonas aeruginosa x 
Shigella sonnet x 
Klebsiella pneumoniae x 
Acetinobacteur baumanii x 
Table 11 Spectrum of activity of bacteriocin (inhibition of growth 11 and no 
inhibitory effect X) 
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Fig. 17. Photograph of blood agar plate showing bacteriocin effects of L. paracasei 
(central vertical streak) on (A) S. pneumoniae. and 2 strains of C. difflcile (B) 459 and 
(C) NCTC 11204. A distinct zone of a haemolysis was seen with the interaction of S. 
pneumoniae and the bacteriocin of L. paracasei (see arrow). 
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C. dicile 459 wo 
Type C. difficile 40 
C. bifermentans %0 
C. sporogenes x 
C. novyi 40 
C. buryricum x 
C. tetani %0 
C. perfringens x 
Table 12 Spectrum of activity of bacteriocin against clostridia species (inhibition of 
growth ; no effect X) 
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5.9 Growth of Lactobacillus paracasei in broth and in biofilm 
L. paracasei exhibited the typical logarithmic growth curve in BHI broth culture, 
reaching titres of 107 cfu/mL at 48h (Figs. 64,65). L. paracasei readily established 
growth on Sorbarod filters reaching titres in excess of> 1011 cfu/filter (Figs. 66,67). 
Effluent titres of L. paracasei were of the order of 2log. lower than biofilm titres. 
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Fig. 64 Growth curve of L. paracasei (") in broth culture 
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Fig. 65 Growth curve of L. paracasei (") in broth culture 
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Fig. 66 Growth curve of L. paracasei in biofilm. Effluent titres (") and biofilm titres 
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Fig. 67 Growth curve of L. paracasei in biofilm. Effluent titres (") and biofilm titres 
(0). 
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5.10 Effect of L. paracasei on growth of C. di/cile in broth culture 
Numerous studies were undertaken to determine the effect of L. paracasei on the 
growth of C. difcile in broth culture. L. paracasei was selected by growth under 
aerobic conditions and C. diJcile, by growth on C. docile selective media. 
An initial study was to determine the time interval at which the bacteriocin was 
produced. Overnight broth cultures of C. dicile (40mL) and L. paracasei (1 OmL) 
were added to 5OmL of BHI broth. This was incubated anaerobically and 5mL was 
removed and centrifuged at 3h, 6h, 12h and 24h intervals. The supernatant and 
filtered supernatant (0.6µ filter) were inoculated into wells of a C. dif cile BHI agar 
plate. Table 13 shows that bacteriocin activity was present at 3h in the unfiltered 
supernatant but the filtered supernatant did not show any activity at any time. 
mmmm 
3h 5mm 0 
6h 10mm 0 
12h 8mm 0 
24h 8mm 0 
Table 13. Time interval at which zone of inhibition of C. diJcile developed, size of 
radius of zone around each well measured in mm. 
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Fig. 68 shows a graphical representation of the results of the effect of L. paracasei on 
growth of C. docile in broth culture using differing ratios of C. diJcile to L. 
paracasei to BHI. C. difcile, alone in broth, exhibited the typical-log. growth curve. 
However, when combination experiments with L. paracasei were conducted, a degree 
of inhibition was shown at a ratio of C. docile: L. paracasei: BHI of 1: 10: 10. At 
ratios of 5: 100: 100, and 1: 100: 100 and 1: 1000: 1000, various degrees of inhibition 
were noted, but titres recovered at 48h. The titres of L. paracasei showed no 
significant inhibition (Fig. 69). 
Fig. 70 again demonstrates some inhibitory effect of the bacteriocin on C. dicile, 
here occurring only when the ratio of L. paracasei was 10 times greater than C. 
difcile. Again, this killing effect was not sustained from 24h. 
Fig. 71 shows the variability with these experiments with an ongoing killing effect of 
the bacteriocin at 12-48h when the ratio of L. paracasei exceeded C. di lcile by a 
factor of >I O. Elimination of the clostridium from broth in three of the samples 
occurred here. 
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Fig. 68 Effect of L. paracasei on growth of C. diff cile in broth culture 
(C. difficile titres) 
(ý)-C. difficile 
(ý)-L. paracasei 
() -1 mL C. difficile :1 OmL L. paracasei :l OmL BHI (1: 10: 10) 
(X) - O. SmLC. d fjrcile: 1 OmL L. paracasei: 1 OmL BHI (5: 100: 100) 
(ýk) - 0.1 mL C. difficile: I OmL L. paracasei: I OmL BHI (1: 100: 100) 
(ý) -0.01 mL C. difficile: 1 OmL L. paracasei: l OmL BHI (1: 1000: 1000) 
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Fig. 69 Effect of L. paracasei on growth of C. difficile in broth culture 
(L. paracasei titres) 
(ý)-C. difficile 
( )-L. paracasei 
-I mL C. difficile :I OmL L. paracasei :1 OmL BHI, 
(X )-O. SmLC. d fficile: I OmL L. paracasei: I OmL BHI 
(*) - 0.1 mL C. difficile: 1 OmL L. paracasei: I OmL BHI 
(0) -0.01 mL C. difficile: I OmL L. paracasei: I OmL BHI 
48h 
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Fig. 70 Effect of L. paracasei on growth of C. diffcile in broth culture. 
C. difficile alone in broth culture 
)- L. paracasei in broth alone 
)- 1mL C. docile: 9mL L. paracasei (C. difficile titres) 
(X )- I OmL C. docile: l OmL L. paracasei (C. diffcile titres) 
(ýk)- 9.9mL C. difficile : 100µL L. paracasei (C. d ffcile titres) 
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Fig. 71 Effect of L. paracasei on growth of C. dlf ficile in broth culture. 
C. difficile alone in broth culture 
L. paracasei in broth alone 
( )- 1 mLs C. docile: I OmL L. paracasei: BHI (C. difficile titres) 
(X )- 0.5mL C. difficile: l OmL L. paracasei: 1 OmL BHI (C. difficile titres) 
(ýk)- I mL C. difficile :l OmL L. paracasei (C. difficile titres) 
(") 0.5mL C. difficile: I OmL L. paracasei (C. docile titres) 
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5.11 Effect of L. paracasei on growth of C. difficile in biofilm 
C. difficile was inoculated onto Sorbarod filters and growth was established for 24 h. 
Two mL of an overnight culture oft. paracasei was then added directly to the filters 
for 24h. There appeared to be little killing effect in these experiments apart from an 
approximate log. reduction in both biofilm and effluent titres when L. paracasei was 
present for 24h. (Figs. 72,73). 
Fig. 74 illustrates an experiment using different volumes of L. paracasei added to 
established biofilms of C docile. Maximum bacteriocin activity occurred with the 
addition of IOmL ofL. paracasei. 
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Fig. 72 Effect of L. paracasei on growth of C. diffrcile in biofilm. 
Control C. diffrcile biofilm (M) 
Control C. diffici/e effluent (") 
C. difficile biofilm with L. paracasei () (C. diffrcile titres) 
C. diffrcile effluent with L. paracasei (X) (C. difficile titres) 
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Fig. 73 Effect of L. paracasei on growth of C. difficile in biofilm. 
Control C. d ffrcile biofilm ( ) 
Control C. d fficile effluent (") 
C. docile biofilm with L. paracasei () (C. difficile titres) 
C. d fficile effluent with L. paracasei (X )(C. difficile titres) 
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Fig. 74 Effect of L. paracasei on growth of C. diJfci/e in biofilm 
ControiC. d . facile biofilm control (0) 
Control C. diffrcile effluent (+) 
C. docile biofilm (1 OmL L. paracasei added) (0) 
C. diifficile effluent (lOmL L. paracasei added) (0) 
C. difficile biofilm (1 mL L. paracasei added) (*) 
C. d fficile effluent titres (1 mL L. paracasei added) (") 
C. difficile biofilm titres (0.1mL L. paracasei added) 
C. diffrcile effluent titres (0.1 mL L. paracasei added) () 
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5.12 Effect of C. difficile on growth of L. paracasei in biofiim 
An experiment was also conducted to see if C. docile had any antagonistic effect on 
the established growth ofL. paracasei in biofilm (Fig. 75). There was no 
demonstrable effect, especially in the filters. 
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Fig. 75 Effect of C. difficile on growth of L. paracasei in biofilm 
Control L. paracasei biofilm (f ) 
Control L. paracasei effluent (M) 
L. paracasei biofilm after addition of 1. OmL C. di fficile(*) 
L. paracasei effluent after addition of l . 
OmL C. dificile (") 
L. paracasei biofilm after addition of 0.1 mL C. docile () 
L. paracasei effluent after addition of 0.1 mL C. dWcile () 
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5.13 Discussion 
The concept ofcolonisation resistance is very important when considering C. docile 
infection. As raised previously in this chapter, the colon contains a complex 
ecosystem, with many individual bacterial species making up the "normal flora". If 
the interaction of a pathogen such as C. difficile with the members of the normal flora 
is to be studied, a model biofilm system needs to be developed. Three representative 
bacteria were chosen here, E. coli, B. fragilis and E. faecalis. All these bacteria grew 
readily on the Sorbarod filters, and in combination experiments with C. difficile there 
was little interference in the titres of the bacteria, at least within the variance of the 
titres in this system. Several experiments were conducted with C. difficile and E. coil 
with the broad spectrum antibiotics, co-amoxiclav and meropenem. Essentially here 
both organisms exhibited resistance to the antibiotics up to a concentration of 16 
mg/L, but for C. difficile in the presence ofco-amoxiclav, it was eliminated from the 
biofilm at 32 mg/L when the starting titre was significantly less, by a factor of 3 logs, 
than the E. coll. In both co-amoxiclav experiments, C. difficile was eliminated from 
the effluent at a concentration of 32 mg/L. 
Screening various possible sources for an agent with antibacterial activity against C. 
difficile identified an isolate oft. paracasei which had distinct activity against the 
clostridium as shown by the "sloppy agar" method on a solid agar base (Fig. 62). This 
organism and its bacteriocin activity had an interesting host range; in addition to C. 
difficile, C. tetani, C. bifermentans, C. novyi, and from a surprisingly different 
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bacterial group, S. pneumoniae, were inhibited. When titred out, overnight broth 
cultures of the Lactobacillus gave the same titre against the different indicator strains, 
as identified by the zones of clearance around all the lactobacilli colonies. 
Attempts to develop a model for this activity in broth and filter biofilms were 
frustrating. In broth some degree of activity against C. difficile could be 
demonstrated, but this effect was very variable. In the biofilm system, a significant 
killing effect was difficult to define. Clearly the role that any bacteriocin-like 
substance can play in the modulation of the growth of C. docile in broth or this 
biofilm system is not as straightforward as identifying the activity on solid media. 
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Chapter Six 
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General Discussion 
It is over twenty years since the association between C. dWIcile, AAD and 
pseudomembranous colitis was first noted. Since then, much has been learned about 
the epidemiology and treatment of this disease, which occurs almost exclusively in 
patients who have had prior exposure to antibiotics (Gorbach, 1999). The normal 
bowel flora is thought to prevent infection via colonization resistance (Reid et al., 
1990). When this is disrupted by antimicrobial therapy, the patient, usually over 70 
years of age, becomes susceptible to infection with C. docile. Most classes of 
antibiotics have been associated with C. docile infection, particularly the 
cephalosporins and clindamycin (Gorbach, 1999). C. dccile is an anaerobic spore- 
producing organism. Patients with diarrhoea due to C. difficile liberate large numbers 
of spores into the environment, allowing the bacteria to survive in adverse conditions 
indefinitely, providing a means for cross-infection (Verity et al., 2001). Other patients 
may ingest small numbers of these spores but provided their bowel flora has not been 
disrupted, they are unlikely to develop infection. Diarrhoea develops only with the 
release of toxins (A and B), that cause mucosal damage and inflammation. The 
diagnosis of C. difficile infection depends on the detection of C. difficile toxins in the 
stool using cell-culture or immunoassay (Brazier, 1998). Metronidazole or 
vancomycin enterally is the mainstay of treatment, while control mechanisms include 
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antibiotic stewardship, use of infection control universal precautions and good 
environmental cleaning. 
Many problems remain to be resolved. The numbers of C. d(cile infections continue 
to rise and C. difficile is now the commonest cause of diarrhoea in the elderly and is 
associated with substantial morbidity and mortality (Wilcox, 1998). A particular 
problem is recurrence of symptoms after successful treatment of initial C docile 
infections. A study by Wilcox and colleagues (1998) confirmed the findings of 
smaller studies that more than 56% of the recurrences of symptoms were due to 
reinfection rather than relapse. Reinfection obviously suggests inadequate infection 
control precautions and relapse was either thought to be due to inadequate treatment 
regimens or germination of spores in the colon post cessation of treatment. 
An analysis of the detailed ecology of the colon must be important in understanding 
its diseases, and for bacteria, their growth in biofilm and interactions must be 
relevant. MacFarlane et al. (1997) discuss growth of organisms in biofilm in the 
gastrointestinal tract. They showed communities of polymer-degrading bacteria and 
other groups of intestinal anaerobes growing on particulate matter. It could be argued 
that growth of C. difJIcile in biofilm may account for treatment failures in those who 
"have "true relapses" of infection, and other aspects of this infection. 
To date there are no detailed studies of anaerobes in biofilm. It is known that 
Porphyromonas gingivalis is associated with dental plaque but the only work looking 
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at biofilm formation by this organism looked at the role of polyphosphate kinase 
(Chen, 2002). Other work involving anaerobes looked at butanol production by 
Clostridium beUerinckii BA 101 in an immobilized cell biofilm reactor (Lienhardt et 
al., 2002). 
There is no previous report characterising an anaerobe in a biofilm mode of growth in 
the laboratory, and the first aim of this work was to determine the growth 
characterisitics of C. docile using the Sorbarod filter system (Struthers, 2000). 
The work presented in Chapter 3 compared the growth of C. difficile in broth culture 
to biofilm growth. Differences were observed in titres in biofilm growth and the broth 
culture (Figs. 4-7). In broth culture, in excess of 108 cfu/mL were reached in 24h 
followed by a1 log. drop, but the titre then remained stable as the isolate used 
sporulated at high frequency (Fig. 9). The titres in the filters were maintained for 72h 
with values of>109 cfu/filter being achieved, and these titres were often stable over 
the 72 h period (Fig. 6). It is thus reasonable to state that the organism was in a 
steady-state growth. Thin sections of filters growing C. difficile showed irregular 
microcolonies of bacteria about 10-50 µm in dimensions. (O'Connell et al., 2003). 
These results are similar to other bacteria studied in this system, including 
Gardnerella vaginalis, Lactobacillus acidophilus (Muli and Struthers, 1998), and 
Streptococcus pneumoniae and Moraxella catarrhalis (Budhani and Struthers, 1997). 
The Sorbarod system has revealed unique structures associated with cell division in 
Gardnerella vaginalis (Mull and Struthers, 1998), and that S. pneumoniae reversibly 
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lost its capsule when grown on these filters (Budhani and Struthers, 1998). In this 
latter situation, the Sorbarod biofilms revealed a previously unknown mechanism for 
regulating capsule expression in pneumococcus (Waite et al., 2001). It was thus 
considered relevant to study C. difficile grown in biofilms by both light microscopy 
and TEM. In broth and plate culture, sporulation could be readily detected by 24h, 
and the vegetative bacteria showed the polymorphism recognized in the clostridia, 
with the length varying between 1.2 and 4.5 µm. In the biofilm system, longer 
elongated structures in excess of I0µm in length, and occasionally there were short 
spirals (Fig. 13). Electron microscopy studies showed that these were probably due to 
cell division, without cell separation actually occurring (Fig. 24). Apart from this 
feature, there was no other identifiable difference between the vegetative cell in broth, 
plate or biofilm. The major difference between the different sources of bacteria was 
the absence of spores in the filters. This clinical strain readily formed spores in broth 
and on plates, so it is reasonable to consider that the Sorbarod filter system allows the 
organism to maintain a continuous culture biofilm mode of growth for at least 72 
hours. The relevance of this is discussed later. 
Determination of toxin by the EIA showed higher concentrations of toxin were 
achieved when the organism was grown biofilm in comparison to broth and the 
effluent. While this may have reflected to some extent the differences in titres 
between the various growth modalities, there may be differences in the control of 
toxin expression. Although there were inconsistencies in repeat experiments, it seems 
reasonable that these differences are real. Clearly there are no reports on the kinetics 
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of toxin expression in biofilm or broth culture, and this would be a worthwhile area to 
investigate in future work. 
With the first three aims of the thesis addressed, and the biofilm system for C. 
difficile in the filters being defined, the important area of antibiotic susceptibility was 
then investigated. Initial studies involved antimicrobial sensitivity testing using tube 
tests. The MIC values of C. dilcile to benzylpenicillin, vancomycin and 
metronidazole correlated with those documented (Kucers and Bennett, 1987). 
However, MBC values showed a degree of tolerance, usually in excess of 128 mg1L. 
A number of clinical isolates were investigated here, and it is probably worthwhile to 
embark on a more detailed national study of MIC and MBC values, especially as 
MBC determination has not been considered before with this organism. This may be 
of considerable importance, considering that the site where CDAD is being treated, as 
the contents of the colon are to an extent unusual. High enough concentrations of 
antibiotics need to reach the colonic contents to effect killing. The roles that 
adherence of the organism to enterocytes, the presence of IgA antibodies and the 
presence of phagocytic cells such as neutrophils needs to be further defined, in this 
context. 
This resistance pattern was not surprisingly found in the filters using benzylpenicillin, 
vancomycin and metronidazole, reflecting the accepted resistance to antibiotics in a 
biofilm system (Gander, 1995; Budhani and Struthers, 1997; Muli and Struthers, 
1998; Struthers, 2000). It should be noted that when these resistant bacteria in the 
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filters and effluent were plated onto solid agar and examined directly by disc and 
Etest methods, that the bacteria reverted to the sensitive phenotype. 
With rifampicin, the results were different in that an "acceptable" MBC value was 
obtained in broth culture. This result was consistently repeated in the filter effluent, 
with an EfMBC of between I and 4 mg/L being achieved in three experiments. On 
one occasion, in an experiment controlled by a tube MIC, a BEC of 8 mg/L was 
achieved (Fig. 33). Vancomycin BEC experiments up to 256 mg/L were also 
conducted, and these showed resistance up to this value (Figs. 35,36). Addition of 
rifampicin at fixed concentrations of I and 8 mg/L showed a definite killing effect, 
probably due to some form of synergy. 
The range of antimicrobial concentrations used in these experiments was based on the 
known pharmacokinetics of each antibiotic. With benzylpenicillin, metronidazole and 
rifampicin, conducting experiments with concentrations of up to 32 mg/L are 
appropriate, as the range up to this value relates to the pharmacokinetics of these 
agents in the human (Kucers and Bennett, 1987). It is appreciated that 
benzylpenicillin is not used in the treatment of CDAD, but has a usual half-life of 
only 30min with only some active penicillin excreted via the bile (5-10%) with the 
rest excreted in the urine or is inactivated in the liver. Rifampicin does not reach high 
levels in the lower GIT, and only 60% of a single dose is excreted in the faeces. 
Metronidazole is well absorbed from the GIT with 14% of an administered dose 
being excreted in the faeces. With vancomycin, the situation is different, for via the 
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oral route, it is poorly absorbed, and high concentrations, in the order of 200-300 
mg/L are obtained in the colonic fluid (Kucers and Bennett, 1987). The tolerance of 
the C docile to vancomycin and metronidazole and the possible synergistic effect of 
rifampicin could be of relevance to the treatment of CDAD, particularly in light of the 
frequency of treatment failures, and noting the report that the combination of 
vancomycin and rifampicin is effective in treatment (Buggy, 1993). 
As discussed above, the testing of toxin by the EIA did have a degree of variability 
associated with it, and this is reflected in the toxin experiments done here. It is 
worthwhile to note that at the lower antibiotic concentrations in particular, the level of 
toxin was significantly lower in the effluent than that in the filter. The reasons for this 
are unclear, but may indicate that significant toxin production is associated with 
biofilm formation. It is worthwhile to note that in their investigations of ß-lactamase 
production by M catarrhalis, Budhani and Struthers (1998) showed that levels of this 
enzyme in the Sorbarod biofilms were in the order of 200-fold lower in the filters 
than in broth or effluent based on relative organism numbers. In a comparison of 
protease production in planktonic and biofilm, Evans et al. (1994) reported that the 
production of protease by S. epidermidis was higher in biofilm populations but in a 
study by Tait and Sunderland (2002), they showed that single species planktonic and 
single species biofilm cultures of Enterobacter gergoviae produced similar quantities 
of protease and microcin. 
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Colonisation resistance is very important when considering C. difficile infection as 
the colon contains a complex ecosystem, with many individual bacterial species 
making up the "normal flora". Antagonistic and cooperative reactions, which lead to 
the establishment of pathogenic organisms, are known to occur (Reid et al., 1990). A 
further aim of this work was to investigate combination growth of various organisms 
with C. docile to determine if there were any obvious interactions. E. coli, B. fragilis 
and E. faecalis grew readily on the Sorbarod filters (Figs. 47-52). In combination 
experiments with C. docile similar high titres were achieved, despite some reports of 
interference between clostridia and the growth of E. coli in the large intestine (Itoh 
and Freter, 1989). Again, when antibiotic susceptibility testing was conducted in E. 
coli and C. docile combination biofilms, both organisms exhibited resistance to the 
antibiotics (Figs. 58-61). 
Another objective of this work involved screening various possible sources for an 
agent with antibacterial activity against C. difcile. An isolate of lactobacillus was 
identified, L. paracasei, and was found to have distinct activity against the 
clostridium as shown by the "sloppy agar" method on a solid agar base (Fig. 63). This 
organism and its bacteriocin-like activity had an interesting host range; in addition to 
C. docile, other clostridial species and S. pneumoniae were inhibited. Previous work 
has showed that C. d fficile could be inhibited by several different strains of faecal 
streptococci (Malamou-Ladas and Tabaqchali, 1980). Another report documented the 
role of an antimicrobial substance from a human Lactobacillus sp. strain GG which 
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inhibited members of the family Enterobacteriaceae, Pseudomonas spp., 
Staphylococcus spp., and Streptococcus spp. as well as C. difficile (Silva et al., 1987). 
It has been suggested that production of a bacteriocin would give an organism a 
competitive advantage when interacting with other microbes in providing a 
"foothold" in colonizing a new environment. Bacteriocins may also prevent the 
colonization of a pre-established microbial community by a competitive species 
(colonization resistance) (Marsh and Bowden, 2000). In their review of the ecological 
role of bacteriocins in bacterial planktonic cultures, Riley and Gordon (1999) stated 
that bacteriocin-producing and bacteriocin-sensitive strains cannot coexist; one strain 
will always be outcompeted. Tait and Sutherland (2002) did a study which showed 
that the same may not be true of biofilms. They showed that bacteriocin-producing 
and bacteriocin- sensitive strains can co-exist in biofilm communities. Attempts to 
develop a model for this activity in broth and filter biofilms were frustrating. In broth 
some degree of activity against C. difficile could be demonstrated, but this effect was 
very variable. In the biofilm system, a significant killing effect was difficult to define 
which is similar to findings by other studies (Tait and Sunderland, 2002). It is 
apparent however, that the bowel ecosystem is very complex and much research is 
warranted into understanding the concept of colonization resistance and the interplay 
between indigenous flora and pathogens. Naaber et al. (1997) suggest that lactobacilli 
play a significant role in the maintenance of resistance to C. docile colonization in 
various populations and hospitalized patients. A recent meta-analysis on the role of 
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probiotics in prevention of AAD suggests their usefulness but their efficacy in 
treatment needs to be proved (D'Souza et al., 2002). 
In vivo, biofilms are probably very common in the human body, and the colon is 
likely to be no exception. Here, as elsewhere, biofilm growth will provide a protective 
environment that effectively prevents attack by antimicrobials, biocides, and host 
defence mechanisms (De Lancey Pulcini, 2001). In the work here, the Sorbarod 
biofilm filter system has been adapted to a novel purpose. It is reasonable to conclude 
that it can be used to study C. difcile, which is an important and expensive pathogen 
in medicine. Further work should continue. In order to do this more sophisticated 
markers of metabolism need to be used, for example RNA expression of genes for 
sporulation and toxin production. With these markers, more detailed work on the 
effects of antibiotics should be done, when the organism is on its own and in 
combination with other bowel bacteria. The antibacterial activity of the Lactobacillus 
needs to be characterized in more detail and purified for further work. Investigation of 
such entities may be of future clinical relevance. 
Another important piece of investigative work that needs to be done is to prepare 
chemically defined media that grow not only C. docile but other bowel organisms. 
The Sorbarod system is ideal for such work, as established biofilms can be left 
undisturbed. Using a chemically defined medium, and via the T connector upstream, 
individual components can be withheld, and their effect on the growth, toxin 
production, susceptibility to antibiotics and bacteriocins could be determined. 
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In conclusion, the work presented here is a novel investigation of one of the most 
important pathogens causing hospital-acquired infection, and lays the basis for future 
exciting investigation. 
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